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Human adipose tissue is a good source of mesenchymal (adipose) stem cells which can be used 
in bone tissue engineering both in studying differentiation and for treating patients. Bone 
morphogenetic protein 2 (BMP-2) is often used in culture medium to differentiate mesenchymal 
stem cells in vitro and in vivo, even thiough its efficacy has been questioned. The mechanical 
properties of the substrate the cells grow on have been found important to the outcome of 
differentiation. The aim of this study was to investigate the effects of an electrospun BMP-2 
releasing polymer scaffold which enables controlled and targeted drug-release on the 
adipogenic and osteogenic differentiation of human adipose stem cells in vitro. 
 
Human adipose stem cells (hASCs) from four different donors were cultured on the electrospun 
polymer material, loaded with BMP-2. The properties of BMP-2 scaffolds and control scaffolds 
(CTRL) were compared in basal medium (BM) or osteogenic medium (OM) with or without 
added BMP-2. The osteogenicity of the materials was evaluated using quantitative alkaline 
phosphatase activity assay (qALP), as well as Alizarin red staining and gene and protein 
expression of marker genes using quantitative real time polymerase chain reaction (qPCR) and 
Western blotting (WB). The proliferation and morphology of hASCs were studied using total 
DNA quantification and immunofluorescence respectively. The adipogenicity of the material 
was evaluated using qPCR as well as Oil Red O staining and fluorescence imaging.  
 
It was found that hASCs seemed to grow in aggregates on the BMP-2 scaffolds when compared 
to CTRL scaffolds. The BMP-2 released from scaffolds did not significantly increase the cells’ 
ALP activity and mineralization of ECM. Instead the BMP-2 releasing scaffolds and CTRL 
scaffolds seemed to bolster adipogenic differentiation based on the shape of the cells and 
increased intracellular fat as well as the qPCR results. However, no statistically significant 
differences were observed between cells grown in different conditions when the results from 
different cell lines were pooled. It seemed however from the morphological data that the cells 
grown on BMP-2 releasing scaffolds were more similar to adipocytes than osteoblasts. 
 
It was determined that BMP-2 releasing scaffold material is more beneficial for adipogenic than 
osteogenic differentiation. This is probably a result of the material not being stiff enough and 
being too hydrophobic. It is likely that the amount of loaded BMP-2 is too low, as it was 
significantly lower than the concentrations regularly used in differentiation protocols.  
 
Key words: Adipose stem cells, mesenchymal stem cells, osteogenic differentiation, 
adipogenic differentiation, BMP-2, drug releasing scaffold, tissue engineering.  
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Ihmisen rasvakudos on hyvä lähde mesenkymaalisille (rasvan) kantasoluille, joita voidaan 
käyttää luukudosteknologiassa, sekä solujen luuerilaistukseen tähtääviin 
kantasolututkimuksiin, että hoitoihin. BMP-2 on kasvutekijä, jota käytetään useissa 
luuerilaistusprotokollissa laboratorioissa sekä myös kliinisesti, vaikka sen tehokkuus on 
kyseenalaistettu useissa tutkimuksissa. Tämän tutkimuksen tarkoitus oli tutkia kohdennetun ja 
hallitun lääkeaineen vapautuksen mahdollistavan sähkökehrätyn polymeeriskaffoldin 
vaikutuksia rasvan kantasolujen luu- ja rasvaerilaistukseen. 
 
Neljän eri luovuttajan rasvan kantasoluja (hASC) viljeltiin sähkökehrätyllä BMP-2:ta 
luovuttavalla polymeeriskaffoldilla. BMP-2 skaffoldien ja kontrolli–scaffoldien (CTRL) 
vaikutuksia vertailtiin basaali- ja ostoemediumesissa (BM ja OM) ilman lisättyä BMP-2:ta sekä 
sen kanssa. Materiaalien luuerilaistamisominaisuuksia arvioitiin alkaalifosfataasientsyymin 
aktiivisuuden perusteella (qALP) ja Alizarin Red -värjäyksellä, sekä tutkimalla kohdegeenien 
ja -proteiinien ilmentymistä kvantitatiivisen polymeraasiketjureaktion (qPCR), sekä Western 
Blot –tekniikan (WB) avulla. Solujen lisääntymistä ja morfologiaa tutkittiin kokonais-DNA:n 
määrän määrityksellä sekä immuno–fluoresenssimikroskopialla. Rasvaerilaistumista arvioitiin 
solujen sisäisen rasvan Oil Red O-värjäyksellä ja mikroskopoinnilla, sekä qPCR:n avulla. 
 
hASC:t kasvoivat kasaantuneina BMP-2 skaffoldeilla kontolliskaffoldeihin verrattuna. 
Materiaalista vapautuva BMP-2 ei merkittävästi lisännyt solujen ALP aktiivisuutta tai 
mineralisaatiota. Sen sijaan BMP-2 skaffoldit vaikuttivat lisäävän rasvaerilaistumista solujen 
muodon, sekä lisääntuneen solujen sisäisen rasvan määrän, sekä qPCR-tulosten perusteella. 
Tilastollisesti merkittäviä eroja ei löydetty ryhmien väliltä, kun kaikkien neljän solulinjan 
tulokset yhdistettiin. Morfologisen datan perusteella solut muistuttivat kuitenkin enemmän 
rasva- kuin luusoluja. 
 
BMP-2:ta luovuttavan skaffoldimateriaalin havaittiin olevan enemmän otollinen rasva- kuin 
luuerilaistukseen. Materiaalin hydrofobisuus, ja riittämätön jäykkyys lienevät pääsyyt 
nähtyihin tuloksiin sen ohella, että skaffoldeihin ladatut BMP-2 määrät olivat huomattavasti 
pienemmät kuin mitä normaalisti käytetään erilaistukseen.   
 
Avainsanat: Rasvan kantasolut, mesenkymaaliset kantasolut, luuerilaistus, rasvaerilaistus, 
BMP-2, lääkeainetta luovuttava skaffoldi, kudosteknologia. 
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1. INTRODUCTION 
Bone tissue engineering covers a wide scope of different techniques which aim in healing 
defects in bone. To do this it is imperative to understand the biological and mechanical 
properties of bone as well as how bones form and heal in the human body. 
The concept of tissue engineering was first properly described in Langer and Vacanti (1993) 
where they discussed that by combining cells, growth factors and proper materials it would be 
possible to engineer tissue (Langer & Vacanti. 1993). Since then tissue engineering has grown 
into its own cross-scientific field of study, combining the engineering approach to knowledge 
of biology and medicine. Great advancements have been made in the field to gain insight into 
the mechanisms by which tissues are formed and how their healing can be aided. 
Autologous grafts and synthetic cell free metal implants are the golden standard in treating large 
defects in bones at the moment, as they are osteoinductive, osteogenic and non-immunogenic, 
but autologous bone cannot always be harvested in large quantities for all the defects (Thesleff, 
et al. 2011). Furthermore, there are other disadvantages to autografts than availability: The need 
to operate on two sites and chronic pain. Allografts and even xenografts have been used for the 
same purposes, but they are immunogenic and not as effective or as osteoinductive (Thesleff, 
et al. 2011). Other techniques, such as distraction osteogenesis have been used, but they can be 
very painful or non-effective. A more novel approach is the use of cells, scaffolds and growth 
factors that are implanted at the site of defect and that are to be assimilated to the native structure 
(Padalhin AR, et al. 2014). Novel treatment ideas for bone defects have been surfacing rapidly 
since the conceptualization of tissue engineering by Langer and Vacanti (Langer & Vacanti. 
1993). Clinical trials have been increasingly run on treatments based on cell- or biomaterial 
implants and the combination of autologous stem cells and biodegradable polymers have gained 
more interest lately, due to problems with the conventional treatments based on autologous 
bone implants.  
Adipose stem cells (ASCs) have proven to be a good source of stem cells that can be used in 
bone treatments. ASCs can be harvested in great amounts in an easier procedure than bone 
marrow stem cells and have been shown to differentiate into osteoblasts when properly 
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stimulated with correct growth factors with or without mechanical stimulation. (Thesleff, et al. 
2011) 
There are many ways to stimulate the differentiation of stem cells, but the combination of 
suitable materials with the right growth factors is a strategy that has been thought to be simple 
and effective (Tirkkonen, et al. 2013a). The problem is finding the correct materials and growth 
factors. Stiff extracellular matrix (ECM), which gives support for the osteocytes, is 
characteristic of a bone tissue. The importance of scaffold with proper mechanical and 
topographical properties cannot be overstated, as mechanotransduction is a very important 
factor in stem cell differentiation, especially in bone (D'Angelo F, et al. 2011; Mathieu PS & 
Loboa EG. 2012). An equally important requirement is for the material to mimic the 
topographical environment of the target tissue (Kilian, et al. 2010). The electrospun polymeric 
scaffolds in this study are flexible and topographically variable due to the choice of materials 
and the processing method. Many studies have been conducted to find good combinations, but 
improvements can still be made.  
The differentiation of cells is often directed by growth factors alone: growth factors such as 
bone morphogenetic protein 2 (BMP-2) and vascular endothelial growth factor (VEGF) have 
been shown in many studies to affect the differentiation of mesenchymal stem cells (MSC) 
(Solheim. 1998). In the case of osteogenic differentiation, bone morphogenetic proteins are 
thought to be especially important. Therefore, in this study we have decided to culture cells on 
electrospun polymer scaffolds that slowly release BMP-2, which has been shown to have both 
osteogenic and adipogenic effects on mesenchymal stem cells (Zuk, et al. 2011; Vanhatupa, et 
al. 2015). It is an interesting growth factor to study as it has already been approved for clinical 
use in bone applications by the USA food and drug administration (FDA).  
The material used in this study is a blend of biodegrable and -compatible polymers 
poly(caprolactone) (PCL) and copolymers poly(lactic-co-glycolic acid) (PLGA) (PLGA-PCL). 
These materials have been used extensively in biodegradable bone fixation devices and 
controlled drug-release applications (Garvin & Feschuk. 2005) and the electrospun loose 
structure is considered to be similar to native bone ECM in texture (Rohner, et al. 2003; Lee, et 
al. 2012). 
 3 
The aim of this study was to study the effect of BMP-2 releasing electrospun scaffolds on hASC 
morphology, proliferation and differentiation towards osteoblasts and adipocytes in order to see 
if this combination of material and growth factor is suitable for osteogenic differentiation. 
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2. LITERATURE REVIEW  
2.1 Stem cells 
The discovery of stem cells is often accredited to McCulloch and Till in 1963, although the 
term ‘stem cell’ and the concept dates back to as early as the 19th century. Nonetheless, after 
the paper (Becker Aj, et al. 1963) stem cells have been extensively studied and much progress 
has been made in the medical field thanks to their work. 
Stem cells are an effective, yet controversial treatment method in the eyes of the general public. 
Many people outside the field associate stem cells with embryonic stem cells and falsely think 
that all stem cells are derived from sources that could become a complete human. This is untrue 
as new sources for stem cells are being discovered all the time. As a result, the ethical 
controversies become less prominent when the stem cells can be harvested from adult donors 
with little to no harm to their health (Thesleff, et al. 2011). 
Stem cells are unspecialized cells that retain both their ability to proliferate and their ability to 
differentiate into different cell types and they can be categorized according to their origin, or 
their potency (Alvarez, et al. 2012). Totipotent stem cells can form an entire embryo, including 
the extra embryonic placental cells; pluripotent stem cells can differentiate into all the cell types 
of an organism, but cannot form a new individual. Multipotent stem cells can turn into multiple 
cell types, that are generally limited to cell types from a specific germ layer (endoderm, 
mesoderm or ectoderm) and finally unipotent into a single cell type. The ability to differentiate 
depends greatly on the cell source: as a general rule, the earlier the stage of development, when 
the stem cells are isolated, the greater their potency (Alvarez, et al. 2012). Stem cells can be 
derived from many sources such as embryos, bone marrow and fat, and nowadays even created 
from somatic epidermal cells in the form of induced pluripotent stem cells (iPS)(Takahashi, et 
al. 2008). Figure 1 summarizes some of the properties of different stem cell types. 
Embryonic stem cells (ESC) are pluripotent stem cells that have been studied most extensively 
of all human stem cells. As such they are often the cells to which other stem cell types are 
compared. ESCs have enormous potential to be used in regenerative medicine, but as they are 
derived from embryos they entail equally great ethical issues (Lovell-Badge. 2007). Due to the 
ethical controversies, legislature concerning harvesting and use of ESCs can cause difficulties 
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for both research and clinical treatments. Pluripotent stem cells need to meet a set of strict 
criteria. They need to be able to form structures that have characteristics of endoderm, 
mesoderm and ectoderm. In practice, they need to express pluripotency genes, which show their 
ability to differentiate into all the aforementioned germ layers as well as form embryoid bodies 
in vitro and teratomas and hybrids in vivo(Lovell-Badge. 2007; Stadtfeld & Hochedlinger. 
2010). The tendency to form teratomas is also dangerous for patients. 
iPS have similar potential as embryonic stem cells, impose an increased risk of cancer, due to 
the method their pluripotency is induced: iPS can contain mutations that have accumulated 
during the donor’s life time and as the pluripotency genes are inserted into the genome of the 
cell at random, additional mutations occur and the expression of genes can be altered (Angelos 
& Kaufman. 2015). As a result, iPS cells have seen less clinical use. The first clinical trials in 
tissue engineering using iPS was in treatment of age related macular degeneration but had to be 
discontinued due to safety concerns (https://www.ipscell.com/2015/07/firstipscstop/ 
(04.04.2015)). Instead, iPSs can be used as patient specific disease models, bringing us one step 
closer to personalized medicine (Mou, et al. 2015; Wiley, et al. 2015). 
Mesenchymal stem cells (MSCs) are multipotent stem cells of mesodermal origin which can 
differentiate into many different cell types, such as osteoblasts, chondrocytes and adipocytes 
(Horwitz, et al. 2005; Gir, et al. 2012). They can be isolated from different sources including 
bone marrow or adipose tissue and have been used in a number of clinical applications 
(Thesleff, et al. 2011; Angelos & Kaufman. 2015). MSCs and iPSs have been the center of 
attention for tissue engineering since their discoveries because of two reasons: they can be used 
to regenerate different types of tissues and they do not entail as many ethical issues as 
embryonic stem cells. 
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Figure 1. The relatioships of lineage potential, the expression of pluripotency genes and lineage 
specific genes as well as epigenetic changes (DNA methylation) and the amount of open 
chromatin to stem cells derived at different developmental stages, sites and their potencies. The 
image is adapted from (Berdasco & Esteller. 2011). 
2.2 Adipose stem cells 
Human adipose stem cells are MSCs derived from adipose tissue and they have been shown to 
be multipotent (Gimble & Guilak. 2003), (Zuk, et al. 2001a; Dominici, et al. 2006). They can 
be harvested in greater amounts than bone marrow stem cells (BMSCs) and the procedure is 
easier and less painful to the patient (Thesleff, et al. 2011). A downside for adult stem cells 
(including both BMSCs and ASCs), is that often the derived cell lines have a tendency to 
differentiate into the cell types present in the tissues they were derived from, probably due to 
epigenetic changes (Alvarez, et al. 2012; Lee, et al. 2014b). 
MSCs have the ability to prevent the proliferation of immune cells and can thus be injected at 
inflammation sites to control the immune reaction (Djouad F, et al. 2009). ASCs have been 
shown to be better at immunosuppression than BMSCs (Gir, et al. 2012). Regrettably, this 
property along with the fact that MSCs seem to have the ability to home on cancer cells can be 
harmful, so great care must be taken if a cancer patient is being treated with MSCs (Gir, et al. 
2012; Luo, et al. 2014; Ridge, et al. 2014). However this same homing ability has been 
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suggested as a means for treating cancer, by using the cells to carry drugs, or to destroy cancer 
cells with the aid of suicide genes and the bystander effect (Hu, et al. 2010). Recently, it has 
been shown that human ASCs (hASC) have potential as a means to fight melanoma (Ahn JO, 
et al. 2015). Being immunoprivileged also makes the use of allologous ASCs plausible, which 
means that we may have off the shelves ASC products in the future. Adult stem cells in general 
have one more major advantage over embryonic stem cells and iPSs: The later the 
developmental stage is when the stem cells are isolated, the less likely they are to differentiate 
into cancerous cells (Alvarez, et al. 2012). 
Just a decade ago the existence of adipose stem cells was a controversial issue. It was relatively 
recently in 2001, that the multipotency of these cells was proven (Zuk, et al. 2001b; Zuk, et al. 
2002). Since then the number of tissues they have been successfully differentiated into has 
expanded dramatically from just adipocytes to chondroblasts, osteoblasts, tenocytes, myoblasts 
and even neuron-like cells as well as insulin secreting cells (James. 2013) and many other cell 
types. One of the most interesting properties of hASCs, along with the abundance and 
accessibility of these cells (Strioga M, et al. 2012), is this ability to trans-differentiate into cell 
types normally originating from other germ layers, however reported cases have proven to be 
hard to replicate and the differentiation efficiency has been low. This transdifferentiation ability 
has been questioned as some evidence indicates that the transdifferentiation of adult stem cells 
are actually a result of cellular fusion(Wurmser AE & Gage FH. 2002). 
Whether it is the result of differentiation, transdifferentiation, cell-fusion, growth factor 
production, immune system suppression or a combination of these properties, MSCs and lately 
especially ASCs have shown potential from treatments for diabetes (Gimble, et al. 2007; Gir, 
et al. 2012; Wu H & Mahato RI. 2014) to treating strokes (Gutierrez-Fernandez M, et al. 2013). 
For now, they have been studied and used most extensively clinically in bone tissue engineering 
applications. Autologous hASCs isolated from donor tissues at Tampere University have been 
used in multiple regenerative treatments (Thesleff, et al. 2011; Sandor, et al. 2014). The most 
famous one of these is a case, where a large mandibular defect was repaired using autologous 
hASCs that were expanded ex vivo, differentiated in vivo in the patient’s abdomen and 
implanted to the defect site (Sandor GK, et al. 2013). Although such treatments have not 
become a standard of care yet, they showcase the possibilities.  
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2.2.1 Isolation and donor variability 
Adipose stem cells, as discussed before are isolated from adipose tissue. The source of fat can 
however vary. Mostly the cells are from liposuction or tissue samples from abdominal fat or 
breast reduction surgeries (Zuk, et al. 2001b). 
While cells from different sources show the same ability to differentiate, they can have different 
preferred direction of differentiation. Toyoda and coworkers showed that ASCs isolated from 
subcutaneous fat are better suited for osteogenic and adipogenic differentiation than those 
derived from omental fat (Toyoda, et al. 2009). Studies have shown that while omental and sub-
cutaneous derived cell lines may have different preferences for differentiation, sub-cutaneous 
ones from different regions seem to have relatively similar differentiation profiles. There are 
still a number of unanswered questions and controversies when it comes to the differentiation 
ability of adipose stem cells. Strioga and co-workers showed that the gender of the donor was 
linked to the cells’ ability to differentiate, male cells having a greater tendency for osteogenic 
differentiation (Strioga M, et al. 2012), while in other studies no such connection has been 
found (Toyoda, et al. 2009). The ability to differentiate into osteoblasts has however been 
shown to reduce with growing body mass index and age of the patient (Dechat T, et al. 2008; 
Choudhery MS, et al. 2014). 
Adipose stem cells, when compared to other stem cell types have certain advantages, the most 
obvious ones being that they can be isolated from the patients with little ethical issues and low 
risks or discomfort for the patients and their ability to trans-differentiate. One major benefit is 
their abundance. After isolation, the number of cells is relatively high compared to e.g. BMSCs 
(Strioga M, et al. 2012). Fat grafting operations with fat enriched with ASCs in order to enhance 
the outward appearance of target areas of patients have also been conducted with the idea that 
the added ASCs make the operations more permanent by proliferating in the target area (Gir, et 
al. 2012; Zielins ER, et al. 2015). MSCs derived from different locations have differing 
immunoprivilege properties. Small differences in the expression of surface markers such as 
CD106 make BMSCs more adept at controlling cell-mediated immune responses than e.g. 
ASCs, but no significant adverse effects have been noticed in patients with either cell types 
(Strioga M, et al. 2012). It has been thought that as there are more than 400 000 liposuction 
operations done in the US alone every year, isolating hASCs from the lipoaspirates could prove 
a good source for transplantable cells in the future if hASC treatments become more common. 
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2.2.2 Characterization and classification  
Dominici and coworkers defined the ISCT’s (International Society of Cellular Therapy) 
minimal criteria for mesenchymal stem cells used today (Dominici, et al. 2006). The minimal 
criteria include plastic adherence, certain profile for cell surface markers and the ability to 
differentiate into osteoblasts, adipocytes and chondrocytes. The criteria are summarized in 
Table 1.  
Table 1. Minimum criteria for mesenchymal stem cells (Dominici, et al. 2006). 
1. Adherence to plastic in standard culture conditions 
2. Phenotype Positive(≥95% +) Negative(≤2%+) 
 CD105 CD45 
 CD73 CD34 
 CD90 CD14 OR CD11b 
  CD79α OR CD19 
  HLA-DR 
3. In vitro differentiation: osteoblasts, adipocytes, chondroblasts  
 
CD105, or endoglin is a glycoprotein associated with TGF-β receptors and angiogenesis. CD73 
is a 5’-ectonucleotidase associated with adenosine dephosphorylation and its activity is 
important for osteoblast differentiation (Takedachi M, et al. 2012). CD90, or Thy-1 is a stem 
cell marker present in many kinds of stem cells. All the markers that the cells should be negative 
for according to ISCT are associated with hematopoiesis and the immune system. 
2.2.3 Osteogenic differentiation  
There are several approaches for differentiating stem cells. They can be categorized roughly to 
differentiation via genetic engineering, chemical factors or physical factors. Often they are 
applied at the same time (Zhang R, et al. 2013; Hamam, et al. 2015). Osteogenic and adipogenic 
differentiation have special relationship: One usually inhibits the other (Lin GL & Hankenson 
KD. 2011; James. 2013). This relationship can be pictured as a seesaw, with adipocytes on one 
end and osteoblasts at the other (Figure 2). 
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Figure 2. An illustration of the inverse relationship between adipogenesis and osteogenesis 
modified from(Gimble & Guilak. 2003). 
Osteogenic differentiation occurs in two major steps: commitment into osteoprogenitor cell and 
differentiation into osteoblast. Osteoblasts mature into osteocytes in vivo once they become 
surrounded by the ECM they produce (Solheim. 1998). 
The use of soluble factors to direct the differentiation of adipose stem cells is the most used 
approach.  The wanted differentiation outcome can be reached either by applying activators to 
signaling pathways important to wanted cell type, applying inhibitors to other pathways, or 
both. (Osyczka AM, et al. 2004; Wan DC, et al. 2007). 
Osteogenesis in MSCs is usually orchestrated through the activation of Runt related 
transcription factor-2 (Runx2), which is considered the master regulator of osteogenic 
differentiation. Several factors and cell signaling routes are associated with osteogenic 
differentiation, but most of them converge at Runx2 (Chen, et al. 1998). 
Bone morphogenetic proteins are involved in many pathways leading to differentiation of stem 
cells. BMPs 2, 4, 6 are involved in osteogenesis and BMP-7 in chondrogenesis as well as in the 
differentiation of brown adipose tissue (Tseng, et al. 2008). BMPs bind to BMP receptors 
(BMPR) that phosphorylate downstream signal molecules. There are more than 20 known 
BMPs and several BMPRs, but not all of them are involved with osteogenesis (Hoffman, et al. 
2006). BMP-2 signaling is discussed in detail in section 2.3. 
Osteogenesis Adipogenesis
Osteoblast
Preadipocyte
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Wnt-signaling pathways have been shown to be important for both osteogenic and adipogenic 
differentiation. Canonical Wnt-signaling (Wnt/b-cat) pathway promotes the expression of 
peroxisome proliferator-activated receptor-γ (PPARg), whereas the less well known 
noncanonical pathways have been shown to inhibit it (Lin GL & Hankenson KD. 2011; van 
Amerongen. 2012; James. 2013). Wnt-signaling has also been connected to osteogenesis: 
depending on the initiator of the pathway, the expression Runx2 can also be activated, but the 
general consensus is that Wnt signaling is more relevant for osteoblast differentiation (Lin GL 
& Hankenson KD. 2011). It is also worth keeping in mind that there is evidence that non-
canonical wnt-signaling modulates the osteogenic differentiation of MSC derived from 
different sources differently (Liu, et al. 2014). 
Many growth factors, including a number of bone morphogenetic proteins, fibroblast growth 
factors and vestigial endothelial growth factor 1 (VEGF-1) are associated with increased 
osteogenesis (Tirkkonen, et al. 2013b). For VEGF the mechanism has been shown to be 
intracellular in recent studies: VEGF added to medium has little or no effect (Liu et al. 2015). 
VEGF controls the amount of Lamin A/C in the nuclear envelope. Lamin A/C is associated 
with mechanotransduction as well as increased osteogenesis and suppressed adipogenesis.(Li 
W, et al. 2011; Vidal C, et al. 2012). 
Genetic engineering can encompass many techniques from RNA-interference to adding genes 
to the cells, either transiently via plasmids, or long term with integration to the genome using 
integrative viruses (Zhang R, et al. 2013; Hamam, et al. 2015). Genetic engineering is made 
use of when inducing pluripotency into somatic cells by turning them into iPS (Takahashi, et 
al. 2008). The process involves inducing the expression of a set of pluripotency genes (usually 
Oct3/4, Sox2, Klf4, c-Myc)(Alvarez, et al. 2012; Schlaeger TM, et al. 2015). Similar approach 
can also be used to induce the expression of osteogenic transcription factors, or using RNA-
interference to inhibit the expression of other transcription factors or proteins that suppress 
osteogenesis (Peterson B, et al. 2005; Lian, et al. 2012; Zhang R, et al. 2013). 
It is general knowledge that the ECM surrounding a stem cell can greatly affect its 
differentiation. This is why different materials having different chemical and physical 
properties are used to direct the differentiation of cells (Wang YK & Chen CS. 2013). Several 
signaling pathways in a cell are activated or enhanced by the rigidity or elasticity of the material 
the cell grows on (D'Angelo F, et al. 2011; Cassidy JW, et al. 2014). These mechanical factors 
can also be induced with other means, such as vibration and changes in pressure. These kinds 
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of stimulations are usually induced by speaker systems and pressurized air that pushes and pulls 
a scaffold on which the cells are growing (Tirkkonen L, et al. 2011). Electric current and 
magnetic fields can also be used to guide the differentiation of cells either by manipulation of 
the material or directly affecting the cells (Parssinen J, et al. 2015). 
The constituents of OM are optimized to promote osteogenic differentiation. The OM used in 
this study was optimized for adipose stem cells by (Tirkkonen, et al. 2013a). The composition 
is listed in Table 2. Ascorbic acid increases osteogenesis, by up regulating type I collagen 
secretion. L-glut acts as a source of energy and has been shown to greatly improve osteogenesis. 
Type 1 collagen is a major constituent in the ECM of bones and glutamine, which is prevalent 
in the protein structure, has been shown to induce collagen synthesis in cell cultures 
(Langenbach F & Handschel J. 2013). Dexamethasone, a synthetic glucocorticoid is a drug 
which is used to treat a number of diseases in humans. Its relevant effects for osteogenesis 
include the activation of glucose metabolism and lipolysis (Mikami Y, et al. 2011). Less 
dexamethasone is used in the OM optimized for ASCs than in the traditional OM used for 
BMSCs (Tirkkonen, et al. 2013a). β-glycerophosphate acts as a source of phosphate that is 
needed for the mineralization of ECM (Halvorsen YD, et al. 2001; Langenbach F & Handschel 
J. 2013).  
 
Figure 3. Showing interactions between well-known signaling pathways regulating Runx2 
activation. Arrows indicate activation and lines inhibition. TCF/LEF is a transcription factors 
that can activate Runx2. Adapted from (Lin GL & Hankenson KD. 2011).  
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2.2.4 Adipogenic differentiation  
As adipocytes act as the body’s energy reservoir, insulin, glucocorticoids and other factors 
involved in metabolism, such as insulin like growth factors are important factors in 
determination of adipogenic differentiation (Ali, et al. 2013). Activating, or preventing the 
inactivation of pathways that increase the intake of fatty acids and other high-energy molecules 
such as carbohydrates in general leads to adipogenic differentiation rather than osteogenic 
differentiation (James. 2013). 
Many of the same signaling pathways that are involved in osteogenesis are also associated 
directly or indirectly with adipogenesis, which makes it difficult to control the differentiation 
process towards one or the other outcome. Adipogenic differentiation, just like osteogenic 
differentiation occurs in two steps: Commitment into preadipocyte and differentiation into 
adipocyte. While preadipocytes are committed to become adipocytes under normal 
circumstances, recently it has been shown that treating them with all trans retinoic acid, which 
is an activator of lamin expression, can turn the cells into osteoblasts (Liu Y, et al. 2014). 
Adipogenic differentiation is controlled by many factors, but PPARg is considered to be the 
master regulator (Mikami Y, et al. 2011; James. 2013). CCAAT-enhancer-binding proteins 
(C/EBPs) are activators of PPARg, which in turn when activated, can upregulate the expression 
of C/EBPs in a positive feedback loop. Correspondingly, inhibiting this signaling pathway 
downregulates adipogenesis (Mikami Y, et al. 2011).  Adipocyte protein 2 (AP2) is another 
protein that is controlled by PPARg and has been found to control the adipose differentiation 
(Darlington, et al. 1998). It is a carrier molecule needed in fatty acid uptake, transport and 
metabolism and its expression level rises especially in the preadipocyte to adipocyte transition. 
This gene alone is not a specific adipocyte marker as it is also expressed in leucocytes and 
stromal vascular fraction (SVF) cells, but it has been shown to be important for adipogenic 
differentiation (Shan, et al. 2013). 
Adipogenic differentiation of MSCs in vitro requires higher cell concentrations than osteogenic 
differentiation (McBeath R, et al. 2004). While osteogenesis is not prevented by multiple cell-
cell contacts, they are a requirement for adipogenic differentiation, as cells are scarce in mature 
bone and plentiful in adipose tissue. Similarly the amount of focal adhesion complexes between 
the ECM and the cells increases osteogenic and decreases adipogenic differentiation (Mathieu 
PS & Loboa EG. 2012). Moreover, several studies have shown that morphology is important 
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to hASC differentiation outcome. Whereas osteogenic differentiation needs the cells to be in 
spread out morphology, adipogenic differentiation requires a round shape for the cells 
(McBeath R, et al. 2004; Kilian, et al. 2010; Mathieu PS & Loboa EG. 2012).  
Just as osteogenic differentiation is encouraged in OM, there is also an adipogenic medium. Its 
individual components each have an effect, which aims at adipogenesis. Dexamethasone as a 
glucocorticoid has also several effects that benefit adipogenesis, including the uptake of glucose 
and activation of metabolism in general (Rubin, et al. 2009). Insulin increases the uptake of 
glucose, needed for the typical action of adipocytes: storage and synthesis of fat. Biotin is 
needed for the first steps in fatty acid synthesis and has been shown to act as an activator of 
PPARg. Isobutyl-methyl-xanthine has several effects, but its main effects are caused by its 
action as a phosphodiesterase inhibitor. In this role, it helps to prolong the effects of insulin, by 
increasing the intracellular lifetime of secondary messenger cyclic adenosine monophosphate, 
which has been shown to be important in the early phases of adipocyte differentiation. The 
combination of the above mentioned substances and their synergistic effects have been shown 
to be good for adipose differentiation of hASCs. (Ali, et al. 2013) 
To make things interesting the control of osteogenic and adipogenic differentiation is controlled 
by many known signal pathways which overlap at several points: Wnt-signaling, Hedgehog-
signaling, Notch-signaling, BMP-signaling and insulin like growth factor-signaling all share 
common mediators (Lin GL & Hankenson KD. 2011). As a result, some substances, e.g. 
dexamethasone seem to induce both osteogenesis and adipogenesis. This can in part be 
explained by line specific differences and timing of administering the substances: for example, 
Mikami and coworkers showed that early exposure to dexamethasone contributes to adipogenic 
differentiation and inhibits the action of BMP-2, but cells treated with BMP-2 gain a synergetic 
advantage for osteogenesis, if dexamethasone is added later on (Mikami Y, et al. 2011). Lee 
and co-workers studied a similar set-up and concluded that TNF-α in turn inhibits the action of 
dexamethasone and increases the potency of BMP-2’s osteogenic properties (Lee, et al. 2014b). 
Contradictions in studies involving the balance between these two differentiation outcomes are 
numerous and the subject needs further studying, before a clearer picture of the process is 
gained. In general, it can be said that the sum of different stimuli results in the balance of 
adipogenesis and osteogenesis tipping one way or the other. Proteomic studies that specifically 
look at the effects of BMP-2 or other growth factors while certainly expensive, could prove 
invaluable. 
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2.3 BMP-2  
Bone morphogenetic proteins belong to TGF-β family of growth factors and are associated with 
differentiation pathways in many stem cells (Solheim. 1998; Lin GL & Hankenson KD. 2011). 
BMP-2 and BMP-7 are both used for chondrogenic and osteogenic differentiation of 
mesenchymal stem cells, and the latter has been used for brown adipocyte differentiation (Gir, 
et al. 2012). Bone morphogenetic proteins are involved in skeletogenesis, organogenesis and in 
fracture healing. Many BMPs have osteogenic effects, but not all of them are essential for the 
formation of bone. While BMP-4 has been use for both chondrogenic and osteogenic 
differentiation, BMP-2 and not BMP-4 has been shown to be essential in endochondral 
ossification, one of the two major mechanisms by which bone is formed in the body (Shu B, et 
al. 2011; Lin GL & Hankenson KD. 2011). Bone morphogenetic proteins, including BMP-2 
are produced in fracture sites and BMP-2 has been found to be essential for the initiation of 
fracture healing (Tsuji K, et al. 2006). 
ASCs have been used in multiple bone regeneration applications with or without additional 
BMP-2 (Thesleff, et al. 2011; Seppanen R & Miettinen S. 2014). The growth factor has been 
shown to be beneficial for the healing of bone defects in mice (Peterson B, et al. 2005). 
However, in these studies the inclusion of ASCs seem to have little or no effect on the healing 
process (Peterson B, et al. 2005), which suggests that BMP-2 might not affect the osteogenic 
differentiation of ASCs significantly, but instead work on preosteoblasts already present in an 
in vivo situation. Said studies have shown that in ASCs downstream transcription factors such 
a Distal –less box 3 are not activated by BMP-2 induced signaling, which they believe to 
suggest that the signaling route itself does not function as expected. Another important point to 
keep in mind when comparing studies is that most of the studies that our current understanding 
of MSC differentiation are based on, are conducted in murine and rat models, where the results 
are usually more clear. Applying this understanding to humans has proven difficult and the 
results have been more varied (Osyczka AM, et al. 2004). Vanhatupa and coworkers came to 
the conclusion in their extensive in vitro study that the effects of BMP-2 are donor dependent 
(Vanhatupa, et al. 2015).  
2.3.1 BMP-2 signaling pathway  
BMP-2 pathway begins with BMP-2 binding with BMP-2 receptors, which dimerize to gain the 
ability to phosphorylate SMADs. Two or more phosphorylated receptor regulated SMADs 
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combine with co-SMADs and enter the nucleus, unless inhibitory SMADs combine with the 
complex. Once the SMAD-complex enters the nucleus, it acts as a transcription factor. The 
access to nucleus can be inhibited by nuclear envelope proteins such as MAN1 (Dechat T, et 
al. 2008), which are in turn controlled by Lamin A/C and intracellular VEGF (Berendsen AD 
& Olsen BR. 2015). 
There are a total of 9 different SMAD proteins in humans that can be classified into three 
categories: Receptor regulated SMADs (SMADs 1, 2, 3, 5 and 8/9), which are phosphorylated 
by the receptors, the common mediator (co-SMAD) SMAD 4 and inhibitory SMADs (SMADs 
6 and 7) (Heldin CH, et al. 1997). BMP-2 induces the formation of SMAD1/5/8 complex, which 
can be used as a marker for activated signaling pathway (Lin GL & Hankenson KD. 2011). 
BMP-2 has been shown to induce both osteogenesis and adipogenesis depending on the dosage 
and the BMP-receptor it binds to: Binding to BMPRI-A induces adipogenesis and binding to 
BMPRI-B osteogenesis (Chen, et al. 1998; Kang, et al. 2009).  BMP-2 pathway, when activated 
by BMPRI-B induces the expression of Runx2 –expression factor, which is the master regulator 
of osteogenesis and antagonist of PPARg, the master regulator of adipogenesis, the expression 
of which is increased by the same pathway activated through BMPR1-A. High doses of BMP-
2 have been associated with osteogenesis, but exceedingly high doses can cause unwanted 
phenotypes (Zara JN, et al. 2011). On the other hand, low doses of BMP-2 seem to be beneficial 
for adipogenesis (Chen, et al. 2016) 
The pathway and its regulators are still not fully understood so interfering with one factor of 
the pathway can yield unpredictable results. Some studies suggest that the effects of BMP-2 on 
ASC differentiation are not significant at all (Peterson B, et al. 2005; Zuk, et al. 2011). 
Vanhatupa and coworkers came to the conclusion that the effects of BMP-2 are donor specific 
(Vanhatupa, et al. 2015). 
Noggin is an extracellular protein that acts as an antagonist for many bone morphogenetic 
proteins and thus inhibits the pathway (Chen, et al. 2012). There is evidence that noggin is 
excreted as a regulator for BMP- signaling through a feedback loop and its inhibition has thus 
been recently studied as a possible means to enhance osteogenic differentiation (Wan DC, et 
al. 2007). The results have varied: While some early research was interpreted so that noggin is 
required for osteogenesis, the current consensus is that its inhibition is more beneficial. The 
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noggin feedback loop has been thought to be one reason, why the effects of BMPs are so varied 
on different cell lines (Osyczka AM, et al. 2004). 
 
Figure 4. BMP-signaling pathway leading to Runx2 activation. Adapted from (Lin GL & 
Hankenson KD. 2011). 
2.3.2 BMP-2 as a drug  
BMP-2, along with BMP-7, have been approved by FDA to be used in treatment of bone 
defects. However, BMPs have several other roles in the human body and high doses in the 
wrong places can lead to apoptosis, unwanted differentiation and even cancer (Zara JN, et al. 
2011; Kim, et al. 2013). Furthermore, the production of BMPs for medical use is expensive. 
Therefore, new ways to administer the growth factor locally need to be studied.  
Osteopenia and osteoporosis are sometimes treated with BMP-2, but it is used especially in 
spinal fusion surgeries (Carragee EJ, et al. 2011). Safety issues have led to lawsuits against 
companies using recombinant human BMP-2 (rhBMP2). Spinal fusion constructs such as 
INFUSE bone grafts have been shown to increase the risk of certain types of cancer and male 
sterility (Zara JN, et al. 2011; Carragee EJ, et al. 2011); 
http://www.drugwatch.com/infuse/(13.02.15)) among other serious and less serious 
complications. Nonetheless the improved quality of life after a vertebrae fusion in patients and 
the ease of the operation when using BMP-2, have kept the products on the market. BMP-2 has 
also been used in combination with biomaterials in clinical bone tissue engineering applications 
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at the University of Tampere (Sandor, et al. 2014). In one case BMP-2 was adsorbed on β 
tricalcium phosphate (TCP) scaffolds, by incubating the biomaterial for 48h in a solution that 
contained 12mg BMP-2 (Sandor GK, et al. 2013). Later these scaffolds, with autologous hASCs 
were implanted in the patient. 
2.4 Polymer scaffolds in bone tissue engineering  
Materials can be categorized into metals, ceramics, polymers and composites (Piskin. 1995). 
Biodegradable polymers are the most used in bone tissue engineering, followed by ceramics 
and composites. 
Metals have been used for bone fixing devices for a long time, but have certain disadvantages 
compared to the other material groups. Metals have superior mechanical properties compared 
to bone so when metallic implants are used in load bearing bones, the bone surrounding the 
implants degrades slowly due to the micromovements of the metal and due to weakening caused 
by the metal bearing most of the weight. This effect is called stress shielding (Engh CA, et al. 
1987). Due to this, other materials which more closely match the properties of bones are desired 
for long time implantation.  Ceramics have mechanical properties comparable to bones and 
certain ceramics, such as bioactive glasses and hydroxyapatite have osteoinductive properties 
(Waselau M, et al. 2012; Ojansivu M, et al. 2015). The major problems associated with 
ceramics are that they are brittle, their tensile strength is weak and they are hard to process. 
Biodegradable polymers are the most widely used scaffold materials for bone tissue 
engineering. This is a result of multiple factors: Very little stress shielding, surface topography 
can be easily processed and drug release can be controlled (Garvin & Feschuk. 2005; Li, et al. 
2006). A number of polymers, especially biodegradable ones, have been studied for scaffold 
purposes in bone applications. These polymers can roughly be categorized as natural or 
synthetic biodegradable polymers (Li, et al. 2006). 
Natural biodegradable polymers, such as chitosan, silk and collagens, are derived from 
organisms and generally have excellent biocompatibility, but may contain contaminants due to 
their origins and processing (Lee, et al. 2012). They are generally hard to process, as they are 
sensitive to changes in heat, pH and other conditions. Furthermore, as they are usually degraded 
enzymatically in vivo, the degradation rate is hard to control as people have varying expression 
levels of said enzymes. (Li, et al. 2006). In contrast, synthetic biodegradable polymers are more 
easily processed and their degradation rates are easier to control. They are, as a result of being 
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synthetic, less likely to have contaminants and are generally more easily sterilized. Some of the 
most common synthetic polymers used in bone applications include polylactide, polyglycolide, 
polycaprolactone and polytrimethylene carbonate (Garvin & Feschuk. 2005; Vo TN, et al. 
2012). As a down side the degradation products can be acidic depending on the polymer. 
Both natural and synthetic polymers as well as their combinations have been used in bone tissue 
engineering both in vitro and in vivo (Piskin. 1995; Rohner, et al. 2003). The intended use of 
materials determines which materials and processing methods are best suited for the task. The 
needed processing methods can also affect the choice, as natural polymers are sensitive to 
variations in temperature and chemical surroundings (Lee, et al. 2012). If the material needs to 
give mechanical support to broken bones, fix ligaments, or needs to have a controlled drug 
release rate, synthetic polymers are generally good. If maximum biocompatibility in the form 
of cell attachment is required to assist in healing, natural polymers are often better suited for 
the task (Porter, et al. 2009). 
2.4.1 Poly(lactic-co-glycolic acid) and poly(caprolactone) 
Poly(glycolide) is a polymer derived from glycolide and has been widely used in biodegradable 
sutures (Sill TJ & von Recum HA. 2008). It has a glass transition temperature around the 
physiological temperature, which makes it rather flexible in in vivo applications. Its degradation 
in a biological environment occurs in two phases: First random hydrolysis of the polymer and 
second, entering the formed glycolic acid into the citric acid cycle. The polymer is ultimately 
broken down to carbon dioxide and water. 
Lactide is a chiral molecule, meaning that it has two optical isotopes referred to as enantiomers. 
The two enantiomers have different degradation rates. Poly(lactide) can consist of one or both 
of the enantiomers in varying ratios and can thus have varying degradation rates. It has a glass 
transition temperature of around 70 °C, making it rather rigid in vivo (Madhavan Nampoothiri 
K, et al. 2010). By varying the ratios of the enantiomers, the degradation rate of the polymer 
can be controlled. The degradation of PLA results in the formation of lactic acid lowering the 
pH. In vivo lactic acid is transported to the liver and converted to glucose in gluconeogenesis. 
Poly(lactide-co-glycolide) (PLGA) is a copolymer of PLA and PGA, which is used extensively 
in biomedical applications. It is bulk eroding, as are the homopolymers. PLGA can have varying 
ratios of PLA or PGA monomers and this ratio is responsible for the rate of degradation in vitro 
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and in vivo. Varying the ratio makes it possible to control the rigidity and the drug release rate 
of the material (Garvin & Feschuk. 2005; Madhavan Nampoothiri K, et al. 2010). 
Polycaprolactone is a polymer, whose degradation rate is much slower than those of PLA and 
PGA (Woodruff & Hutmacher. 2010). PCL is typically used in applications where the needed 
degradation time for the material is more than a year. By adding PCL to the polymer blend, the 
interval of controlled drug release lengthens and longer lasting mechanical support for the cells 
is achieved. Owing to its low glass transition temperature, (-60°C)(Kurniawan D, et al. 2011) 
PCL is also less rigid than PLA, PGA or PLGA and can be copolymerized or blended with the 
material to make the total construct more flexible. Both PLGA and PCL degrade by bulk 
erosion, meaning that the scission of bonds occurs throughout the structure, and water can enter 
the material bulk. PCL like PLA, PGA and their copolymers have been extensively used in 
sutures, and fixation devices (Woodruff & Hutmacher. 2010; Madhavan Nampoothiri K, et al. 
2010). 
2.4.2 Electrospinning  
Electrospinning is a process in which polymer melt or a solution containing polymers dissolved 
in it, is ejected through a nozzle and the emerging string is spun by a magnetic field and 
collected on to a charged collector(Bhardwaj N & Kundu SC. 2010). Figure 5 illustrates the 
electrospinning process. By varying different parameters such as the size, or sometimes the 
number, of nozzles, the state of the polymer, the voltage of the nozzle, different kinds of 
polymer fibers and patterns can be gained. 
Electrospun materials are typically very sparse, thin and mesh-like sheets (Bhardwaj N & 
Kundu SC. 2010). The polymer strings can move with respect to one another. This makes the 
material flexible, which can be good or a bad thing depending on the intended use of the 
material. 
Very different polymers can be electrospun: Both natural polymers such as chitosan and 
synthetic ones such as polyurethanes can be used to form sheets (Lee, et al. 2012). Because 
solution electrospinning does not require the temperature to be raised above melting 
temperature of the polymers, growth factors and other medicinal molecules that are heat 
sensitive can be incorporated into the fibers with their biological activity intact, during the 
spinning process (Sill TJ & von Recum HA. 2008; Bhardwaj N & Kundu SC. 2010). 
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Alternatively the drug can be loaded after the material has been spun, making it possible to use 
either melt or solution spinning for drug-releasing purposes. 
Melt spinning and solution spinning give different sized strings: Melt spinning can be used to 
give strings with thickness in the micron range, while solution spinning can yield fibers in even 
in 100-500nm thickness range (Bhardwaj N & Kundu SC. 2010). Porogens can be incorporated 
into the melt or the solution to give the resulting fibers even more varying porosity (Woodruff 
& Hutmacher. 2010). All in all, electrospinning can be used to make fibers and scaffolds with 
very different topographical profiles. Scaffolds that are biodegradable and release drugs are 
hard to design. Both diffusion of the drug through the material as well as the degradation rate 
of the polymer are important factors: the slower the degradation rate, the more accurately the 
rate of release can be controlled (Bhardwaj N & Kundu SC. 2010). One method to control the 
drug-releasing properties of an electrospun material is to make a layered polymer with a 
technique called core-shell spinning. Here the inner and outer layers have differing degradation 
rates, making it possible to have a time delayed release of the drug. Alternatively the drug can 
diffuse through the two layers at different rates (Sill TJ & von Recum HA. 2008). 
 
Figure 5.A Schematic drawing of solution electrospinning: A polymer solution is pushed 
through a charged taylor cone and the formed fiber, spun by an electromagnetic field is 
gathered on a collector. 
 
2.4.3 Surface topography and chemistry 
Surface topology and chemistry play a major role in cell attachment and differentiation just as 
the mechanical properties of the material. The best results are obtained, when the topology and 
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chemistry are similar to the ECM of the target tissue (Haimi S, et al. 2009b; Padalhin AR, et al. 
2014). 
While stiffness of the scaffold has been considered to be a more important factor in inducing 
osteogenic differentiation, if the cells cannot properly adhere to a surface, there is little 
possibility for mechanotransduction occurring. This brings us to surface chemistry: the addition 
of charged proteins, oligopeptides or salts can greatly increase the adherence of cells to 
surfaces. (Haimi S, et al. 2009a; Padalhin AR, et al. 2014; Ojansivu M, et al. 2015). The ECM 
in bones is highly polar due to the presence of the hydroxyapatite, the mineral part of bones. 
Thus hydrophilicity should increase osteogenicity. 
Viswanathan and coworkers studied the effects 3D surface topology on the adhesion and 
differentiation of mesenchymal stem cells and found that porosity had a significant effect on 
stem cell differentiation (Viswanathan P, et al. 2015). Pärssinen and coworkers studied how the 
number and size of focal adhesion complexes are related to osteogenic differentiation of hASCs 
and found there to be a positive correlation between them (Parssinen J, et al. 2015). 
As discussed in earlier sections, cell morphology, or cell shape is a key factor in differentiation. 
What affects the cell shape is the cytoskeleton, which is directly affected by the surface on 
which the cells grow on. Actin is a cytoskeletal component that affects the cell morphology the 
most: it connects to both the protein on the nuclear lamina and to proteins on the plasma 
membrane and thus mediates mechanical signals inside the cell.(Vidal C, et al. 2012). 
Intracellular fat is an indicator to the direction an adipose stem cell will differentiate 
(Vanhatupa, et al. 2015). The more there is fat inside the cells the closer it is to adipogenesis. 
The mechanical and chemical properties of the surroundings of the cells greatly affect amount 
of intracellular fat as a result of activating signaling pathways that either lead to the activation 
or inhibition of genes involved in fat metabolism (Shan, et al. 2013). 
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3. AIM OF THE STUDY 
The aim of this study was to quantify the effects of BMP-2 releasing electrospun PLGA-PCL 
scaffolds on the adipogenic and osteogenic differentiation of hASCs and to evaluate the 
potential of this combination of material and growth factor as a means for increasing osteogenic 
differentiation. The evaluation was based on on hASC morphology as well as proliferation and 
differentiation towards osteoblasts and adipocytes. The main hypothesis in this study wast that 
the BMP-2 releasing scaffolds would increase osteogenic differentiation. 
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4. MATERIALS AND METHODS  
4.1 Isolation and culture of hASCs 
In this study, four different patient cell lines of hASCs were studied. All the hASC lines were 
isolated from adipose tissue samples obtained from patients undergoing elective surgeries at 
Tampere University Hospital, Tampere, Finland, with the patients’ written consents. The 
isolation and use of hASCs were carried out in accordance with the Ethics Committee of 
Pirkanmaa Hospital District, Tampere Finland (ethical approval R03058). 
4.1.1 Isolation 
The hASC lines used in this study were isolated from subcutaneous fat; either from breast 
(human fat stem cell lines (HFSC) 5/13, 5/12 and 38/12) or from abdomen (HFSC 9/13). All 
the donors were women of age 60±5 years. The fat tissue samples were mechanically chopped 
into small fragments with scissors and the ECM further digested with a solution containing 
collagenase type I (1.5mg/mL; Invitrogen, CA, USA) in shaking conditions in a water bath at 
+37°C for 60min. The SVF was isolated by centrifugation at 600g for 10 min and discarding 
all the other fractions. The red blood cells that might remain in the SVF were lysed by 
incubating the fraction in sterile water for 2 min. Osmotic conditions were returned with DPBS 
with added NaCl. Another centrifugation step was performed with the same conditions as above 
and the pellet resuspended in basal culture medium (BM, see Table 2), consisting of Dulbecco’s 
modified Eagle medium Ham’s nutrient mixture F-12 (DMEM/F-12) 1:1 (Gibco®, Thermo 
Fisher Scientific), supplemented with 1 % L-alanyl-L-glutamine (GlutaMAX; Gibco, Thermo 
Fisher Scientific), 1% antibiotics/ (100 U/mL penicillin, and 0.1 mg/mL streptomycin (Lonza, 
Basel, Switzerland) and 5 % human serum (Hspaa) (PAA Laboratories GmbH, Pasching, 
Austria) then filtered through 100µm filter and washed with BM prior to plating. The adipose 
stem cells in the SVF will grow due to their plastic adherence, while other cells wash out during 
passaging. Figure 6 summarizes the isolation procedure. The cells were expanded in T75 cm2 
flasks made of polystyrene (Nunclon™ Delta treated flask; Thermo Fischer Scientific™) to get 
rid of the non-plastic adherent cells. All the media containing Hspaa in this study were sterile 
filtered using Vacucap® 90 PF Filter unit with w/0.8/0.2um Supor® membrane. 
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Table 2. The compositions of BM and OM. 
Components Quantity(BM) Quantity(OM) 
DMEM/F-12 1:1 1x     
Human serum 5 % 5 % 
GlutaMAX 1 % 1 % 
Pen/Strep 1 % 1 % 
L-ascorbic acid 2-
phosphate 200 μM - 
β-Glyserophosphate 10 mM - 
Dexamethasone 5 nM - 
BMP-2 (100 nM) (100 nM) 
Insulin - - 
Biotin - - 
Isobutyl-
methylxanthine - - 
Pantothenate - - 
 
 
 
Figure 6.  A schematic diagram of the primary culture isolation process. 
4.1.2 Characterization 
To verify their mesenchymal origin, all the cell lines used in this study have been characterized 
by showing that they adhere to plastic during isolation and have a pattern of surface marker 
expression in accordance with the guidelines of ISCT see Table 1). The relevant surface marker 
expressions were routinely measured using flow cytometry and the results are listed below. 
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Table 3. Expression levels of relevant surface markers for the cell lines used in the study. 
Information for generalized hASC gene expression combined from (Tsuji, et al. 2014; Satish, 
et al. 2015). 
 
4.2 Primary cell culture 
Cells were cultured in standard cell culture conditions: 5 % CO2 and 20 % O2 partial pressure 
at 37°C in the humidified atmosphere. The cells were expanded in BM and the medium was 
changed twice a week until they were passaged, seeded or frozen under sub-confluency. 
TrypLETM Select (1x) (Gibco®, Thermo Fisher Scientific™), a highly purified animal origin-
free replacement for trypsin, was used to detach the cells from the flasks, after which they were 
centrifuged, supernatant removed, resuspended in BM and counted using a hemocytometer. If 
extra cells remained after the previous procedure, they were frozen. To store the cells, they 
were centrifuged and the pellet resuspended in 1,5ml freezing solution consisting of 10 % 
volume per volume (v/v) dimethyl sulphoxide (DMSO HybriMax™; Sigma-Aldrich, St. Louis 
Missouri, USA) and 90% (v/v) sterile filtered Hspaa. The cell suspension was placed in a 
cryotube and frozen in a freezing chamber filled by isopropanol at -80°C over night (o/n) to 
avoid damage to the cells from quick freezing. The cryotube was moved into gas phase nitrogen 
cryostorage for long time storage.  
When needed for the experiments, cells were taken from the cryostorage, thawed quickly in a 
+37ºC water bath, resuspended in BM and centrifuged to get rid of the DMSO in the freezing 
solution by resuspending the pellet again in BM before moving the cells into T75 flasks for 
further expansion and culturing. The growth and morphology of the cultures were monitored 
routinely using a phase contrast light microscope and hASCs at passage 2-4 were used for the 
experiments in order to ensure that there was very little spontaneous differentiation before the 
experiment.  
HFSC 5/13 HFSC 9/13 HFSC 5/12 HFSC 38/12 Generalized hASC
3 T-cell co-receptor - - - - -
11a Integrin αL - - - - -
14 Serum lipopolusaccharide binding protein - - - - -
19 B-lymphocyte-lineage differentiation antigen - - - - -
34 sialomucin-like adhesion molecule ± - ± - ±
45 Leukocyte common antigen - - - - -
54 I-CAM1 ± - ± - -
73 Ecto-5'-nucleotidase ++ + ++ + ++
80 Human B7-1 cell surface receptor - - - - -
86 Human B2-1 cell surface receptor - - - - -
90 Thy-1 ++ ++ ++ ++ ++
105 Endoglin ++ ++ ++ ++ ++
HLA-DR MHC-II antigens - - - - -
Legend: ++ = Strong expression>85%, +=expression ≤ 85% ≥ 50% ±=Moderate expression < 50% >10%, - = weak or no expression <6%
Expression levelAntigen explanationSurface protein
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4.3 Biomaterials 
The biomaterial scaffolds have been produced in associate professor Joachim Loo’s research 
group at Nanyang Technological University (NTU) in Singapore using solution electrospinning 
on a blend of PLGA and PCL (PLGA-PCL). Two types of scaffolds were produced: ones loaded 
with BMP-2, where BMP-2 was present in the spinning solution and diffused into the polymer 
bulk before the structure of the material was formed, and ones with no BMP-2, referred to as 
control scaffolds from now on. 
The scaffolds were stored at -20°C air tightly to avoid degradation of the polymer chains and 
the BMP-2. The scaffolds were weighed on an analytical scale, then placed on 24 well plates 
and UV-sterilized for 20 min in a laminar hood. Autoclaved cell crowns (Scaffdex, Tampere, 
Finland) were used to pin the materials to the bottoms of the wells, and the scaffolds were pre-
wetted in 1ml of BM for 24 h inside an incubator to get rid of the effects of initial burst of BMP-
2 and possible soluble monomers as well as to wash the material after the UV sterilization. 
According to information from the NTU, after the initial burst, the material releases BMP-2 for 
up to 15d at a steady rate of 0,45ng/10mg/day. The masses of scaffolds varied between 1-10 
mg. 
4.4 Experiment setup, plating and culture 
There were two major setups for the study. Experimental setup I for the main experiment to 
quantify the effects of BMP-2 releasing scaffold material on a cellular level, which was repeated 
with hASCs from four different donors, and setup II to gain information about the effects of 
BMP-2 releasing scaffold material on a RNA and protein levels.  
The experimental setup I consisted of six different hASC culturing conditions (Table 4): Cells 
growing on the control scaffolds (groups 1 and 4), cells growing on the BMP-2 releasing 
scaffolds (groups 2 and 5) and cells growing on control scaffolds with BMP-2 (Sigma) added 
in the culture medium in 100 ng/ml concentration (groups 3 and 6). Groups 1-3 were cultured 
in BM and groups 4-6 in osteogenic medium (OM; see Table 4 on page 28). Four different 
hASC lines, HFSC 5/12, HFSC 38/12, HFSC 9/12 and HFSC 9/13 were cultured under these 
conditions for up to 21d, during which time relative cell number, alkaline phosphatase (ALP) 
activity, mineralization, cell morphology morphology and intracellular fat vacuoles were 
studied as described in more detail below. 
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In the experimental set up II, the HFSC 5/12 cells were cultured in five different conditions 
(Table 4): Cells growing on polystyrene culture plates with and without BMP-2 added to the 
medium (groups 7 and 8, respectively), cells growing on control scaffolds with and without 
added BMP-2 in the medium (groups 9 and 11, respectively) and cells growing on the BMP-2 
releasing scaffolds (group 10). The medium used was starvation medium: BM with only 1% 
(v/v) Hspaa with or without added BMP-2 (50 ng/ml). Western blot (WB) analysis as well as 
qPCR analysis were run for samples taken at 7 and 14 day time points to detect the activation 
of BMP-2 signaling pathway as described in more detail below. 
Table 4. Different culture conditions and groups used in this study. 
Experimental 
setup Group Scaffold Medium 
BMP-2 added to 
the medium 
Cells seeded/ 
1.9cm2 
I 1 CTRL BM - 8000 
I 2 BMP-2 BM - 8000 
I 3 CTRL BM 100ng/mL 8000 
I 4 CTRL OM - 8000 
I 5 BMP-2 OM - 8000 
I 6 CTRL OM 100ng/mL 8000 
II 7 None 1%BM - 10000 
II 8 None 1%BM 50ng/mL 10000 
II 9 CTRL 1%BM - 10000 
II 10 BMP-2 1%BM - 10000 
II 11 CTRL 1%BM 50ng/mL 10000 
 
The pre-expanded hASCs were plated onto the pre-wetted scaffolds as follows: The pre-wetting 
medium was removed and 900ul of BM, BM+BMP-2, OM or OM+BMP-2 medium was added 
on the scaffolds.  Then, the hASCs were seeded onto the scaffolds in 100ul of BM. The number 
of cells seeded/well (1.9 cm2) was 8000 or 10000 for the experimental set ups I and II, 
respectively (See Table 4). 
During the experiments the medium was changed precisely every three days. In the medium 
exchange, 480 μl of medium was removed from each well using a pipette and 500 μl of fresh 
pre-warmed medium was added to make up for medium lost through evaporation.  Three 
parallel samples of each group and of the four cell lines were used in all analytical methods, 
resulting in the total number of parallel samples 12, except for qPCR and immunofluorescent 
microscopy, for which only two parallel samples were used. In addition, a cell-free blank 
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sample was used for each group and for each cell line. The overall work flow and the timing of 
analyses can be seen in Figure 7. 
 
Figure 7. Showing the workflow of the experiments and the analyses run at different time points. 
Experimental set up II analyses in reversed colors. 
4.5 Analyses 
4.5.1 Proliferation 
The relative cell number of the samples was analyzed using CyQUANT Proliferation Assay Kit 
(LifeTechnologies, Thermo Fisher Scientific) based on the total deoxyribonucleic acid (DNA) 
amount in the samples. In the method, the total DNA of the cells is stained, and the absorbance 
is measured, giving a relative amount of cells per sample.  
At time points 7d, 14d and 21d the cells cultured on the biomaterials were lysed by pipetting 
them with 300 μl of 0.1% (V/V) Triton-X 100 in PBS, while scratching the surface of the 
biomaterial. The plates were frozen at -70C to further lyse the cells and wait for the analyses. 
After thawing, the samples were collected into separate micro centrifuge tubes by repeating the 
pipetting and scratching as above and centrifuged to separate the debris from DNA and to get 
rid of the foam that formed during the collection. The cell lysates that were used for CyQuant 
were also used later for quantitative ALP analysis (qALP). 
Three parallel 20 μl samples were pipetted onto a flat-bottom 96-well plate and 180 μl working 
solution (consisting of cell lysis buffer and GR-Dye (CyQUANT® GR-Dye) that was produced 
according to the manufacturer’s instructions was pipetted on the samples. The fluorescence of 
the samples at 480/520 nm was measured using Wallac Victor 1420 Multilabel Counter; Perkin 
Elmer; Waltham, Massachussetts, USA) and the relative cell numbers were considered as 
Preculturing cells
CyQuant (7d, 14d, 21d)  
qALP (7d, 14d, 21d)  
Alizarin Red (14d,21d)  
WB and qPCR (7d,14d)
Preparing biomaterials24h prior to plating
Plating
Immunostaining (3d, 7d, 14d)
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directly proportional to fluorescein counts. Fluorescence from Triton-X-100 was taken into 
account in the final analysis, by subtracting its emission from the samples.  
4.5.2 Fluorescence imaging 
Immunostaining along with fluorescence imaging was used to study the morphology and 
growth patterns of the hASCs as well the amount of lipid droplets inside the cells at 3d, 7d and 
14d. AlexaFluor® 488 Phalloidin (Pha) (ThermoFisher Scientific) was used to visualize the 
cytoskeleton of the cells. Phalloidin works by binding to the fibrous form of actin and 
preventing it from depolymerizing. This allows for the visualization of the cytoskeleton and 
cell shape. The samples were counter-stained with 4, 6-diamino-2-phenylindole-
dihydrochoride (DAPI) to visualize the nuclei of the cells and Oil red O (ORO) to detect the fat 
vacuoles in the cells and the scaffold material.  
The medium was removed and the cells were washed twice with 1ml Dulbecco’s phosphate 
buffered saline (DPBS). The cells were fixed with 4% paraformaldehyde (PFA; Sigma-Aldrich) 
for 60min and washed thrice with 1ml DPBS. The cells were then permeabilized with 0,1% 
Triton X-100 for 12 min and washed again thrice with 1ml DPBS. The cells were then blocked 
with 1% weight per volume (w/v) bovine serum albumin (BSA) overnight at +4°C. 
AlexaFluor® 488 Phalloidin (ThermoFisher Scientific) was diluted 1:300 into the blocking 
solution and the cells were incubated in the 250µl of phalloidin solution for 60min in dark. Prior 
to ORO staining, the cells were washed thrice with 1ml DPBS, once with water and the samples 
were incubated in 400µl 60% isopropanol (2-propanol; EMD Millipore) for 2min. The Oil Red 
O stock solution (Sigma-Aldrich) was diluted 3:2 in milli-Q water, then filtered twice through 
a filter paper and incubated with the samples for 15min. The cells were thoroughly washed four 
times with 1ml water and mounted on slides using Vectashield H-1200 mounting agent that 
included DAPI (Vector Laboratories). All images were taken within one week’s time after the 
staining. OLYMPUS IX51 microscope and DP manager and controller software were used to 
take gray scale images that were modified with Adobe Photoshop CS4 to give color and merge 
them. 
4.5.3 Quantitative ALP activity analysis 
ALP is an enzyme active in the early phases of bone differentiation (Halvorsen et al. 2001; Zuk 
et al. 2001). Its activity is thus an early marker for bone differentiation. The activity is 
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quantitated by providing the phosphatase substrate and the correct alkaline conditions for the 
enzyme to work for a fixed period of time. In the analysis, p-nitrophenyl phosphate is used as 
a substrate. ALP removes a phosphate group from the substrate at pH 10.4 to produce a yellow 
colored p-nitrophenol and a phosphate. ALP concentration in the sample is proportional to the 
rate of p-nitrophenol formation, which can be measured with colorimetry. 
For the quantitative ALP activity analysis (qALP), the same lysate samples that were used for 
CyQuant and collected at 7d, 14d and 21d were used. 0.1% Triton-X-100 was used as a blank. 
The three parallel 20 µl samples were incubated with a working solution consisting of alkaline 
buffer solution (2-amino-2-methyl propanol; 1.5M; pH 10.3; Sigma-Aldrich) and substrate 
solution (p-nitrophenyl phosphate, disodium; Sigma-Aldrich) for 15min at 37 °C. 50 μl of 1M 
NaOH (Sigma- Aldrich) was added to stop the reaction after which the absorbance at 405 nm 
was measured using a microplate reader (Victor Wallac 1420 Multilabel Counter, Turku, 
Finland). The ALP activity and cell numbers were determined from the same cell lysates, which 
allowed for calculating the normalized ALP activity in proportion to cell number. 
4.5.4 Alizarin red staining and quantification 
Alizarin red dye binds to divalent cations such as magnesium and calcium, the latter of which 
is a major constituent of bone ECM. It is a late marker for bone differentiation. The dye can be 
extracted with cetylpyridum chloride solution to quantify the results. 
At time points 14d and 21d the medium and the cell crowns were removed and the cells washed 
once with 1ml PBS. The cells were fixed onto the biomaterials by incubating them in 500 μl of 
4 % PFA for 15-30min at room temperature (RT). The cells were washed twice with distilled 
water (dH2O) and stained with 2 % Alizarin Red S (Sigma-Aldrich) solution (pH 4.1-4.3) for 
10min. The excess dye was washed away several times with (dH2O) and once with 1ml of 70% 
ethanol. The wells were photographed with digital pocket camera Panasonic Lumix DMC-TZ6 
digital camera to gain a qualitative estimate of mineralization. The dye was then extracted by 
incubating the cells in 500 μl of 100 mM cetylpyridium chloride monohydrate (Sigma-Aldrich) 
for 3h at RT on a shaker. Three parallel 100 μl samples from each well were pipetted onto a 
96-well plate and their absorbances were measured at 544nm with a microplate reader (Victor 
Wallac 1420 Multilabel Counter) to quantify the mineralization. 
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4.5.5  SDS-PAGE and Western Blotting 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) is an 
electroforetical method in which proteins are separated based on their molecular weight and 
charges with the help of electric current on a gel. Without the SDS in the gel, the charge of the 
protein affects how its movement on the gel, but as 1,4g of SDS binds to 1g of protein and 
masks its charge, the separation occurs primarily on the basis of protein mass. Once the proteins 
are separated, they can be transferred onto a nitrocellulose membrane using electric current and 
probed directly or indirectly with enzyme conjugated antibodies such as horseradish peroxidase 
antibodies to ascertain the presence of selected proteins in a process known as Western Blotting 
(WB). The workflow is summarized in Figure 8 below. 
 
Figure 8. A diagram showing the workflow for sample preparation and western blotting. 
The medium and the cell crowns were removed from the wells. The samples were washed once 
with 1ml of DPBS and the plates were placed on ice. Cells were collected from three parallel 
wells by scraping into a total of 150 μl of SDS-PAGE loading buffer. The samples were then 
repeatedly drawn and pushed through a 20G needle to aid the lysis of the cells. The samples 
were incubated for 5min at 95°C to denature the proteins and reduce the Cys-Cys sulphur 
bridges in them. The samples were then frozen at -20C°C.  
The 5 μl samples for β–actin analysis and 30 μl for the other analysis and 5 μl of molecular 
weight marker (PageRuler™ prestained protein ladder, Thermo Fischer Scientific™) were 
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loaded onto gels and the gels were run using Mini-protean® Tetra system; BIO-RAD; Hercules; 
California, USA) with 120V voltage, until the lightest of prestained molecular markers reached 
the end of the gel. 
The gels were moved to semidry transfer device (Trans-Blot® SD Semi dry transfer cell; Bio-
Rad; Hercules; California; USA; Electrophoresis Power Supply EPS-601; GE Healthcare) and 
the proteins were transferred onto a methanol (EMD Millipore) activated PVDF membrane 
(Amersham™ Hybond™ 0.45 um PVDF Blotting membrane; GE Healthcare; Little Chalfont; 
UK) with 15 V and 300 mAh, 1h. The membranes were washed with Tris-buffered saline with 
0,05 % Tween 20 (Sigma-Aldrich) (TBST). The non-specific binding sites on the proteins were 
blocked with 5 % (W/V) milk (Non-fat milk powder; Valio; Lapinlahti; Finland) TBST solution 
o/n. After 3 x 5 min TBST washes the membranes were incubated with primary (Mouse Anti-
b-actin; Santa Cruz Biotechnology, Dallas, Texas, USA; Rabbit Anti-Noggin antibody; 
Abcam®, and P-SMAD-antibodies (Cell Signaling Technology, Danvers, MA, USA) (1:1000 
dilutions in 5 % (W/V) milk in TBST) and secondary antibodies (Goat anti-rabbit IgG HRP 
conjugated antibody; Santa Cruz Biotechnology, Dallas, Texas, USA and Goat anti-mouse IgG 
HRP conjugated antibody; Santa Cruz Biotechnology, Dallas, Texas, USA) (1:10000 dilutions 
in 5% (W/V) milk in TBST) for 1h at RT with 3 x 5 min TBST washes in between. After the 
secondary antibody incubations the membranes were exposed to Amersham enhanced 
chemiluminescent substrate (GE Life Sciences) for 5 min to induce chemiluminescence. X-ray 
films (Amersham™ Hyperfilm™ ECL; GE Healthcare) were placed on the blots and developed 
at varying exposure times from 30 s to 15 min. 
Semi quantification of PSMAD and b-actin levels was done using FIJI software package. 
4.5.6 Real time quantitative polymerase chain reaction 
Quantitative real time polymerase chain reaction qPCR was used to compare the relative or 
absolute gene expression levels in cell samples. Expression levels of osteogenic and adipogenic 
genes in different culturing conditions were compared in this study. 
The total RNA was isolated from the samples using a nucleospin kit (Macherey-Nagel 
GmbH&Co.KG, Düren, Germany) at 7d and 14d time points under starvation culture conditions 
according to the instructions of the manufacturer and stored at -70C. A High-Capacity cDNA 
Reverse Transcriptase Kit (Applied biosystems, Foster City, CA, USA) was used to synthesize 
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the cDNA from the mRNA in the isolated total RNA. Reverse transcription was carried out as 
follows: 10 min at 25 °C, 2h at 37 °C, 0,05 sec 85 °C and incubation at 10 °C.  
The expression levels of osteogenic marker genes Osterix (OSX) and Distal-less homeobox 5 
(DLX5) as well as the adipogenic marker genes Human adipocyte protein 2 (HAP2) and PPARg 
were analyzed. The level of Noggin, an extra cellular antagonist of BMP-2 was also analyzed. 
Human acidic ribosomal phosphoprotein P0 (RPLP0) is a gene that codes for a protein in the 
large sub unit of a human ribosome. Its expression levels are relatively constant in the cell so it 
is useful as a reference gene to which all the other expression levels were normalized.  
The qPCR mixture contained 30 ng cDNA, 300 nM forward and reverse primers, and SYBR 
Green PCR master Mix (Applied biosystems). The reactions were carried out with an Applied 
Biosystems 7300 Real-Time PCR System machine using the protocol in Table 5. 
Table 5. The qPCR program. 
1. Activation 50°C 0min 
2.Hot start 95°C 10min 
3.Dissociation 95°C 15sec 
 4.Annealing and extension 60°C 1min 45xBack to 3.  
5. Storage  4°C as long as needed 
 
4.5.7 Statistical analysis 
The amount of parallel samples was sufficient for statistical analysis, excluding WB and qPCR. 
Mann-Whitney test with Bonnferroni correction for the p-values was conducted for the 
CyQuant, qALP and Alizarin Red results. Corrected p-values of 0.05 or smaller were 
considered statistically significant, however no statistical significances in the data between 
different culturing conditions and time points were found in this study. The statistical analysis 
was conducted with RStudio R version 3.1.2 which is a non-commercial software. 
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5. RESULTS 
5.1 Proliferation of cells 
The proliferation of cells was measured using CyQuant cell proliferation assay, as described in 
section 4.5.1. The results of total DNA measurements are presented below in Figure 9. 
 
Figure 9. Relative cell numbers in groups of different cell lines at time points 7-21d. For further 
details in the culture conditions refer to Table 4 on page 28. 
From Figure 9 it can be seen that on average the fluorescein counts, which are relative to cell 
numbers, are higher in OM groups than in BM groups. Similarly there seems to be an inverse 
relation with BMP-2 concentration to cell numbers, except at 14d, where the BMP-2 releasing 
scaffolds in OM have highest Fluorescein counts except for HFSC38/12. The difference in 
average cell numbers between BM and OM groups is most apparent at 14d, but at 21d the 
difference has diminished.  
As can be seen from Figure 9. HFSC 5/12 seems to have the most cells in any given group at 
any given time point, while HFSC 9/12 has the least cells at 14d group 2 and again at 21d group 
5. Most variation in cell numbers between the groups can be seen at time 14d especially between 
groups 2 and 5 as well as 3 and 6. Least changes between groups can be observed with cell line 
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HFSC 9/13. The general trend is that OM samples have more cells and the cell numbers increase 
with time. 
5.2 Morphology and intracellular fat results 
The results of morphology studies are seen in the form of immunofluorescence images below. 
While only images of HFSC 9/13 are shown, images taken from HFSC 9/12 were virtually 
indistinguishable from those presented with respect to growth patterns, morphology and 
intracellular fat vacuoles. 
From Figure 10 it is apparent that cells grow in tight clusters on the BMP-2 releasing scaffolds 
throughout the study. Figure 10 also shows that the cells proliferate faster in OM than in BM 
and that cells grow as clusters on the BMP-2 releasing scaffold material. The intracellular fat 
cannot be seen at this magnification, but in images with higher magnification such as in Figure 
11, the fat is easily distinguishable.  
Throughout the study from 3d to 14d, intracellular fat was present in all the groups. From Figure 
11, it is apparent that there are fat vacuoles present in the groups and time points, where the 
least and most osteogenic differentiation is hypothesized to have occurred. There is however 
considerably less fat present in CTRL + BMP-2 in OM group at 14d than at group CTRL in 
BM group at 3d (Figures 11 A and D respectively).  
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Figure 10. Comparing the growth pattern of HFSC 9/13 in different culturing conditions at 
time points 3d, 7d and 14d. 
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Figure 11. 40x magnified Pha-ORO-DAPI staining of HFSC 9/13 showing 40x magnified 
representative images of cells in groups where the least (A, C) and most (B, D) osteogenic 
differentiation was expected to take place BM at 3d and 14d (A, C) and cells cultured on control 
scaffolds in OM + BMP-2 at 3d and 14d (B, C). Scale bar= 200 μm. Green= 
Phalloidin/cytoskeleton, Red=ORO/material/fat vacuoles, Blue=DAPI/nucleus. 
5.3 Early differentiation results 
The results of qALP related to the total DNA results are presented below in Figure 12 below. 
As discussed in section 4.5.3, ALP activity is an early marker for osteogenic differentiation.  
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Figure 12. Results of normalized qALP. The cell line average absorbances measured at 405 nm 
and normalized to the total DNA represented as individual values. Black bars represent the 
average of all the cell line values. 
As can be seen from Figure 12, the relative ALP activities vary greatly between cell lines and 
it is hard to see any similarities between them. For HFSC9/12 there seems to be an inverse 
relationship between BMP-2 concentration and activity at 14d, although it is not statistically 
significant. For the rest of the cells lines at 14d in OM, it seems that the BMP-2 scaffold groups 
have the highest ALP activity. Interestingly on average the lowest ALP activities, when 
comparing BM and OM groups at any time points, can be seen in groups where the BMP-2 
concentrations are highest. At 21d, the BMP-2 scaffold groups have the highest ALP activities 
on average as well, although the results from HFSC38/12 differ from the other cell lines. The 
most obvious changes between ALP activities within time points are seen between BM and OM 
groups 
5.4 Mineralization results 
Images taken from the Alizarin red stained biomaterials at 14d and 21d can be seen in Figure 
13 and Figure 14 respectively. The results of Alizarin red stain quantification related to cell 
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numbers are presented below in Figure 15. As discussed in section 4.5.4, mineralization is a 
late marker for osteogenic differentiation and therefore samples were not collected at 7d. 
 
Figure 13. Digital images taken from individual scaffolds at 14d time point. The cells were 
cultured in set up condition I and stained with Alizarin red. 
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Figure 14. Digital images taken from individual scaffolds at 21d time point. The cells were 
cultured in set up condition I and stained with Alizarin red. 
 
While Alizarin red analysis was made to analyze the mineralization of different groups, these 
images also show the material. The variance in the quality of the materials is made apparent, 
when comparing images taken from the individual wells. It can be seen how the thickness of 
the material varied and how the individual scaffolds were not even and straight, but rather had 
the tendency to curl up on their own without the cell crowns. 
Differences in mineralization between 14d and 21d are clearly visible when comparing Figure 
13 and Figure 14 respectively. The differences between BM and OM groups are also clear, but 
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no major differences can be seen between groups that differ only in the BMP-2 concentration. 
The quantified data can be seen in Figure 15. 
 
Figure 15. The results of Alizarin red Staining related to cell numbers. Cells were cultured in 
set up conditions I. 
While there seems to be a lot of variation between the groups within time point 21d as well as 
when comparing the results between groups at both the time points, there are no statistically 
significant differences owing to the great variation between cell lines within groups. 
Interestingly at 14d OM groups have slightly lower mineralization than BM ones. For 
HFSC9/12 BMP-2 increasing BMP-2 concentration seems to increase mineralization at 14d, 
but lower it in BM at 21d. The differences are however minor. Excluding HFSC9/12, at 21d 
the BMP-2 scaffold group has highest mineralization for all the cell lines in BM. Interestingly 
excluding HFSC5/12 the reverse is true in OM. However, the greatest differences in 
mineralization can be seen between OM and BM at time points. 
5.5 WB and Activation of SMAD signaling 
The results of the WB and immunodetection are presented are presented below on the parts that 
are representable in Figure 16. 
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Figure 16. The results of WB immunodetection. A) Above, the relative β-actin levels between 
groups and below, the relative PSMAD levels at 7d and 14d. B) The expression levels of 
phosphorylated SMAD1/5 normalized to β -actin levels and related to CTRL group at d7.   
From the β-actin expression results (Figure 16 A) it seems that at 7d the cells fare best in groups 
without any BMP-2. Furthermore the cells seem to grow best either the bare well or on the 
control scaffold. At 14d plastic+BMP-2 group has the most cells followed by CTRL scaffold 
group. 
From Figure 16 it can be seen that SMAD phosphorylation has not occurred at 7d in plastic and 
plastic + BMP-2 groups, but at 14d the signaling pathway has been activated in all the groups. 
The PSMAD levels are however highest at 7d groups and there seems to be a trend, that shows 
phosphorylation to be directly related to BMP-2 concentration in cells grown on the substrate. 
Interestingly at 14d it looks as if BMP-2 has an adverse effect on the SMAD phosphorylation 
in cells grown on plastic, but an opposite effect if the cells are cultured on the substrate.  
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Unfortunately the blots stained with anti-noggin antibodies had so much background that they 
could not be scanned with our equipment. The films could only be interpreted when looked at 
against direct light. The noggin WB results were similar to the qPCR results (Figure 17 E), 
showing that the protein expression was highest in BMP-2 containing groups.  
5.6 Expression of marker genes 
The results of qPCR are summarized below in Figure 17. Osteogenic marker gene expressions 
are highest at 7d in the groups where BMP-2 has been added to the medium, while the opposite 
seems to be true for the adipogenic ones. This is most obvious when looking at OSX and PPARg, 
at 7d. hAP2 levels stay relatively constant on the substrates. At 14d the hAP2 expression follows 
a similar trend to that of PPARg on 7d. The highest PPARg expression can be seen on CTRL 
scaffolds without additional BMP-2. 
When comparing the PPARg and DLX5 results (Figure 17 C and B respectively) it seems that 
the material by itself is adipogenic, but the addition of BMP-2 turns the expression levels 
around from adipogenic to osteogenic. hAP2 expression, in contrast to this, is showing the 
plastic to be more adipogenic than the material at 7d. 
The noggin expression is highest in groups with added BMP-2 at 7d and also higher in the cells 
cultured on bare wells than on control or BMP-2 scaffolds. At 14d the expression is low in all 
groups.  
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Figure 17. relative expression levels of marker genes for osteogenesis (A, B) adipogenesis (C, 
D) and BMP-2 antagonist Noggin of cells at 7d and 14d cultured in set up conditions II. The 
expression levels are normalized to RPLP0 and related to Plastic groups at 7d.  
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6. DISCUSSION 
BMP-2 releasing scaffolds were used in this study in order to differentiate adipose stem cells 
into osteoblasts. This study is a part of a series of investigations to search for good materials, 
growth factors and their combinations to optimize osteogenic differentiation of hASCs. The 
results of this study will help to narrow down said combinations. 
The effects of the material, BMP-2 and their combination were assessed using techniques that 
are a standard in the field of adipose stem cell research. Proliferation was assessed using 
CyQuant, which quantifies the total DNA and RNA in a sample. Osteogenic differentiation was 
assessed using alkaline phosphatase activity assay and quantitative alizarin red staining, as well 
as qPCR of key regulator genes DLX5 and OSX and WB of PSMAD, a key component of a 
BMP-2 related signaling route important for osteogenesis. Adipose differentiation was 
evaluated using qPCR for hAP2 and PPARG, important marker genes for differentiation. In 
addition to the aforementioned methods, the cells were observed using fluorescence microscopy 
to see their shape, growth patterns and intracellular fat, which are qualitative indicators for 
differentiation.  
As can be seen from the results section no statistically significant relation between BMP-2 
concentration and any of the parameters such as ALP-activity, Alizarin red staining or cell 
numbers was observed from the pooled data. The individual stem cell lines had different 
reactions to the conditions so no generalizable conclusions can be drawn from the data. While 
the general trends seen in the behavior of the cells is not statistically significant, the results 
themselves are significant in the sense that combined with literature they give us ideas in which 
direction to focus our efforts when designing future studies. 
6.1 Evaluation of results 
BMP-2 is a growth factor known well in the field of bone differentiation and has even been 
used in clinical treatments (Sandor GK, et al. 2013; Sandor, et al. 2014). There are contradicting 
views and results in literature concerning the effects of BMP-2 on hASC differentiation that 
must be kept in mind when evaluating the results. Some studies say that BMP-2 is beneficial 
for osteogenesis (Dragoo, et al. 2003), while others say it isn’t (Peterson B, et al. 2005; Zuk, et 
al. 2011). Many studies have investigated the different outcomes of using BMP-2 for osteogenic 
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differentiation and tried to make sense of the results that sometimes indicate the effects to be 
more beneficial for adipogenesis (Chen, et al. 1998; Kang, et al. 2009). Vanhatupa and 
coworkers in their recent study came to the conclusion that the effects are patient or donor 
specific (Vanhatupa, et al. 2015). This makes sense in the light the effects that genetic 
variability or epigenetic changes of donated cells can have on the effects of BMP-2 on hASCs 
(Takada, et al. 2012): for example the expression of different BMPRs, that favor either 
osteogenesis or adipogenesis (James. 2013). 
6.1.1 The Effects of BMP-2 on hASC proliferation and differentiation 
High amounts of BMP-2 have been shown to decrease the proliferation or even cause apoptosis 
of different cell types, including hASCs (Tirkkonen, et al. 2013a) and osteocytes (Kim, et al. 
2013). The decrease in proliferation is not unexpected, as cells tend to lose their proliferative 
capabilities after differentiation. In some studies BMP-2 has likewise been shown to increase 
the amount of intracellular fat(viite), but here oil red o -staining could not be used quantitatively 
to assess if BMP-2 affects the amount of intracellular fat in the current study, because the 
biomaterial itself binds the staining agent.  
BMP-2 has been shown to have varying effects on hASC differentiation (Vanhatupa, et al. 
2015). Similarly the potency of BMP-2 has been shown to be dependent on the organism it has 
been produced in. The BMP-2 that was added into the culture media in this study was 
recombinantly produced in E. coli. BMP-2 produced in E.coli has been shown to be less 
bioactive than that produced in eukaryotic organisms (Vanhatupa, et al. 2015). The BMP-2 used 
in the scaffolds was also produced in E. coli.  In the literature BMP-2 have been added to culture 
media in greatly varying amounts for MSC differentiation. The amount of BMP-2 released by 
the scaffolds in current study is many folds lower than that typically used in bone 
differentiation: as mentioned in section 4.3, the BMP-2 release rate of the scaffolds was 
0,45ng/10mg/day for up to 15d and their masses varied between 1-10 mg. With the medium 
changes taking place every third day, the concentrations remained very low. Lysdahl and 
coworkers tested extensively the BMP-2 stimulation time and concentrations on BMSCs and 
suggest that exposure to concentrations of as low as 10 ng/ml for 15min were more effective 
for osteogenesis than continuous exposure to BMP-2 in concentrations similar to those used in 
current study (Lysdahl, et al. 2014). At another extreme, in the clinical treatment reported by 
Sandor and co-workers the scaffold was incubated in a solution with 12mg BMP-2 (Sandor 
GK, et al. 2013). While the drug release profile was not reported in the study, it could be 
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assumed that the hydrophilic surface adsorbed more than the amount reported in the current 
study. Unfortunately in the current study no statistically significant differences between groups 
exposed to different amounts of BMP-2 were found when proliferation, ALP activity and 
mineralization were studied. This is partly due to the great variance between the individual cell 
lines. There were not enough individual samples to make statistical studies from the qPCR and 
WB results, but the former showed great differences in the expression of marker genes between 
different culturing conditions. 
In the current study, the cells grow in greater numbers in OM than in BM, which can be seen 
both in the fluorescence images and the quantitative cell number analysis results (Figure 10 and 
Figure 9 respectively). Cell numbers are smaller in in BMP-2 containing groups, which is 
logical as BMP-2 is a signal molecule that should promote differentiation and not proliferation. 
This is also supported by β-actin WB results at 7d in set up conditions II (Figure 16 A). Similar 
results were gained by Kyllönen and co-workers concerning BMP-2 and especially BMP-7 
(Kyllonen, et al. 2013). From Alizarin red and qALP results it can be seen that osteogenic 
differentiation occurs in OM better than in in BM, as expected. The choice of medium seems 
to have more effect on the differentiation outcome than the amount of BMP-2 present. This is 
consistent with studies performed by Tirkkonen and co-workers (Tirkkonen, et al. 2013b). The 
qPCR results in the current study indicate a similar relationship, but from Figure 17 it seems 
that adipogenesis occurs better without BMP-2. However as discussed before, no statistical 
analysis could be performed from the qPCR results. 
The WB results show that PSMAD were present in higher concentrations at 14d time point than 
at 7d and that the group that was grown on plain well without BMP-2 had the least PSMAD of 
any group at both time points (Figure 16). PSMAD activation could not be quantified in groups 
that grew on plain wells with or without additional BMP-2 at 7d, due to nonspecific stains on 
the blot, but the levels were so low that it is likely there was very little activation. Likewise it 
could be seen that the BMP-2 scaffold and CTRL+ BMP-2 groups had the most SMAD 
phosphorylation, which is logical as they had the most BMP-2. 
From Figure 11 one can see that the amount of intracellular fat decreases, but does not 
disappear, when comparing 3d images with no BMP-2 in BM to 14d images with BMP-2 in 
OM. It is possible that at 2 weeks the differentiation has not advanced to a stage where fat has 
disappeared as from the Alizarin red data we can see that at 21d the mineralization is much 
higher than at 14d. It would have been interesting to be able to continue the study until 21d, 
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take images and compare the amount of fat to the Alizarin Red results. Another possibility is 
that faster differentiating adipocytes have already disappeared and with them the greater fat 
vacuoles. 
Taking into account all the results in literature and in this study, it seems that BMP-2 reduces 
proliferation of hASCs and increases osteogenic differentiation. This is true for both set up 
conditions I and II, although it is good to keep in mind the variation between the cell lines and 
that SMAD phosphorylation and gene expression were only studied on a single cell line 
(HFSC5/12). 
6.1.2 The effects of the substrate on proliferation and differentiation 
The choice of scaffold material and its manufacturing process have been shown to be important 
to the viability and differentiation of MSCs (D'Angelo F, et al. 2011). Both the physical and 
chemical properties as well the topography of the materials have an effect on the behavior of 
cells (Lee, et al. 2014a). Ceramics, especially the highly polar and stiff ones, such as bioactive 
glasses, have been shown to be beneficial for osteoblast differentiation (Haimi S, et al. 2009a; 
Sandor, et al. 2014; Ojansivu M, et al. 2015). Polymers, having lower Young’s moduli 
compared to most ceramics and being hydrophobic, have been found in studies to be more 
adipogenic than osteogenic in general. Special patterning, however can tip the scales in the 
favor of osteogenesis (Choi, et al. 2006). All the polymers their copolymers and blends used in 
the current study have also been successfully used in in earlier studies or in bone fixation 
devices (Garvin & Feschuk. 2005; Woodruff & Hutmacher. 2010). The ease of shaping and 
producing different topographies on polymers coupled with their drug loading and releasing 
properties makes them very tempting materials for bone applications, especially in combination 
with more osteogenic ceramics. 
The topographical properties of polymers can be made to resemble that found in bone ECM 
using for example electrospinning such as in this study: The formed mesh is loose enough to 
allow for ingrowth of lamellopodia and filopodia, as can be seen from the images. While 
electrospinning is used mostly with polymers, also composites of polymers and ceramics have 
been used. Polini and coworkers studied osteogenic differentiation of MSCs on PCL and PCL 
composites in vitro without growth factors and noticed that osteogenesis can be achieved also 
in BM, but polar composite substrates were better than plain PCL (Polini, et al. 2011). This also 
is consistent with in vivo studies with PCL blends (Padalhin AR, et al. 2014). This sort of 
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composite material mimics very closely the properties of live bone: the ceramics are like the 
mineralized part of bone ECM and the polymers are like the collagens that provide the bones 
with tensile strength and gives the structure greater fracture toughness (Rho, et al. 1998; 
Weiner, et al. 1999). This kind of composite material if made more three-dimensional could be 
the best choice for bone differentiation, but not necessarily with these particular constituents. 
Classic studies have shown that forcing the shape of cells to change can make BMSCs 
differentiate into either adipocytes or osteoblasts: if they are forced into a round shape, the cell 
differentiates into an adipocyte and if the shape is more spread, the cells differentiate into 
osteoblasts (Thomas CH, et al. 2002). Similar results have also been reached with ASCs (Kilian, 
et al. 2010). In addition to micro patterning they also discussed the importance of the stiffness 
of substrates on osteogenesis. On a flat surface, porous or not, the shape is determined by the 
cells ability to spread on the material (Cassidy, et al. 2014). Due to this, the topography and 
mechanical properties of the scaffold become important: the surface must be stiff enough to 
withstand the forces the cells exert on it as they pull themselves into a spread shape, and porous 
enough to allow for the cell adhesion (Kilian, et al. 2010; Lee, et al. 2014a). 
Based on the topography, the material used in this study should be beneficial for osteogenesis 
as the cells should be able to spread out. While electrospinning provides a topography that 
would seem beneficial for osteogenic differentiation, the material and its individual threads 
might not be stiff enough: especially as polycaprolactone is a constituent of the blend 
(Woodruff & Hutmacher. 2010; Kurniawan D, et al. 2011). Hints of insufficient mechanical 
support is given by the immunofluorescence images taken early in the study, where it seems 
that the cells have tried to attach to the material by forming focal adhesion complexes and left 
behind parts of themselves on the material while searching for good binding sites. 
Bead formations in the fibers have a smaller surface area to volume ratio which slows down 
degradation (Vo TN, et al. 2012). The material is bulk eroding, which should in theory be better 
than surface eroding materials for cell adhesions: The cells should be able to attach better to a 
surface, which is not constantly detaching from the bulk. As the material has varying thickness 
the control of drug release is not easily controlled on the other hand the beads create more 
continuous surfaces to which the cells can adhere more easily. However, microspheres made of 
PLGA, with or without adipogenic drugs, have been used successfully in vivo to differentiate 
hASCs into adipocytes (Choi, et al. 2006; Rubin, et al. 2009; Kelmendi-Doko, et al. 2014). This 
once again underlines the importance of the topographical cues for the cells.  
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Unfortunately, there are no results to compare only the effects of CTRL scaffolds and plain 
wells on hASCs on the morphology of the cells in this study, as no images were taken in set up 
conditions II and no cells were cultured on plain wells in conditions I. As a result we can only 
look at the combined effects of the substrate and BMP-2 on morphology in the next section. 
Whether the changes seen are due to the biological activity of BMP-2 released from the 
scaffold, or due to the effects of drug loading to the mechanical properties of the scaffolds 
cannot be determined and will thus be discussed in the next section, section 6.1.3. 
The cells cultured in set up conditions II expressed higher levels of both PPARg and OSX on 
CTRL scaffolds than on plain wells, but also lower levels of HAP2 (Figure 17). Based on the 
qPCR results it is hard to discern which differentiation outcome is more likely, but factoring in 
the WB results, showing PSMAD on the CTRL scaffolds but not on plain wells, the material 
seems to favor osteogenesis (Figure 16). Whether this is a reflection of the serum poor 
conditions, the actual material properties or their combination, is unclear. The β-actin results 
show that cells proliferate better on plain wells than on the scaffolds at 7d, but not at 14d. 
When comparing cells grown on plain wells and on CTRL scaffolds without added BMP-2, the 
latter seem to be more osteogenic than adipogenic, at least on 7d based on SMAD 
phosphorylation. While there are opposing signaling pathways activated, the available evidence 
tips the imaginary see-saw in Figure 2 in favor of osteogenesis. If morphological data, or 
quantifiable ORO was available from set up conditions II, we could be more confident on the 
matter. 
6.1.3 The combined effects of BMP-2 and scaffold material on 
hASCs  
The effects of combining the scaffold and BMP-2 were studied with qPCR and WB in cell 
culture conditions II, where cells were grown on plain plastic as well as on the CTRL scaffold 
with or without BMP-2 and on BMP-2 scaffold. Data on morphology as well as proliferation, 
ALP activity, and mineralization is available from set up conditions I, but cannot be used to 
evaluate the effects of the material in comparison to plain wells. 
WB and qPCR results (Figure 16 and Figure 17) indicate that the cells grow best on plastic, but 
also fare well on the CTRL scaffolds. The addition of BMP-2 makes the cells proliferate less 
and activates the osteogenic differentiation process by increasing SMAD phosphorylation. 
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PSMAD can also be seen on the CTRL scaffolds and at 7d it seems that the phosphorylation 
increases with rising BMP-2 concentration (Figure 16). 
The morphological data from set up conditions I indicates that the BMP-2 scaffolds are more 
adipogenic than CTRL scaffolds. While there is opposing evidence from the qALP and Alizarin 
red quantification except for mineralization results at 21d in OM (Figure 15), the growth 
patterns of the cells resemble more those of adipocytes’ than osteoblasts’ (Figure 10). 
Bead structures are clearly visible both in the control scaffolds and the BMP-2 releasing ones. 
The width of threads is 400-600 nm, but the beads are up to 7 μm thick.  Due to this it is likely 
that the difference in growth patterns of cells on the control scaffolds and the drug releasing 
ones seen in Figure 10 are not caused by topographical factors, but rather by the effects of drug 
loading weakening the mechanical properties of the material, or the small BMP-2 
concentrations themselves. This would be consistent with a study conducted by Chew and co-
workers, who showed that drug-loading can affect the mechanical properties of electrospun 
polymers (Chew, et al. 2006). 
The isoelectric point of BMP-2 is around pH 8.21 (sequence from 
http://www.rcsb.org/pdb/explore.do?structureId=3BMP and parameters from 
http://web.expasy.org/cgi-bin/protparam/protparam(02.02.16)). This would make the protein 
have a net positive charge at around pH 7. The polar protein inside the substrate could 
destabilize some of the hydrophobic interactions that hold the polymers together, explaining 
the weakening. As a result it would make sense for the cells to seek support from one another, 
resulting in the growth pattern seen on the BMP-2 scaffolds. Another factor, which might affect 
the pattern seen in Figure 10, is the BMP-2 concentration, which can be high in the 
microenvironment, near the scaffold surface where it is being released. The concentration in 
the BM an OM media, when added was however so much greater that it is hard to imagine that 
this could be the case in this study. 
Recently it has been shown that HAP2 down regulates PPARg expression (Garin-Shkolnik, et 
al. 2014). In this light it is logical that in the control scaffold group without BMP-2, where 
PPARG expression is highest at 7d, HAP2 is expressed highest at 14d (Figure 17). As was 
discussed before, the results at 14d might not be very reliable, due to low nutrient conditions 
that are abnormal for the cells, but the results are logical and indicate that the material, by itself 
is more adipogenic than osteogenic at 14d, but the addition of BMP-2 tips the scale towards 
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osteogenesis. Unfortunately due to the scarcity of the scaffolds not enough parallel samples 
could be made to make statistical analysis. However, as these results are only from one cell line 
and as we have already discussed the cell line specificity to reaction with BMP-2 no conclusions 
can be drawn for hASCs in general.  
James and co-workers have shown in an earlier study that BMP-2 can also induce adipogenesis 
(James. 2013). In light of this the properties of the scaffold become exceedingly important if 
osteogenic differentiation is desired. Mechanotransduction is a very important activator of 
osteogenesis. Huang and co-workers showed that osteogenic differentiation of ASCs takes 
place more readily in 3D-cultures than in traditional 2D-cultures (Huang, et al. 2008) and 
Tirkkonen and co-workers showed that in 3D- cultures OM was a more potent inducer of 
osteogenesis than BMP-2, BMP-7 or VEGF and that having these growth factors in BM or OM 
had no significant effect on the differentiation (Tirkkonen, et al. 2013b). From the latter study 
it seems that at least in 3D the scaffold properties are more important than BMP-2. This might 
not however be directly comparable to this study, where the material was somewhere between 
2D and 3D with respect to cells, as they grew in several layers. 
As briefly discussed before, the amount of cells seeded has been shown to be one factor for the 
differentiation direction taken by MSC cells (McBeath R, et al. 2004). As MSCs are plastic 
adherent, it can be expected that the cells might at least initially grow better on bare wells than 
on the hydrophobic biomaterial. It is difficult to determine the optimal number of cells seeded 
on a new biomaterial and in the case of this study the amount was chosen without optimization 
as a result of the lack of scaffold material. This has to be taken into account when comparing 
the results between groups in set-up II. The β-actin levels go a long way to help with this in the 
WB results. Similarly, as the qPCR results are related to the large ribosomal gene the level of 
which is generally considered to be stable in cells regardless of their type the normalization is 
done appropriately. 
The noggin WB could not be scanned due to high background. However, the noggin expression 
levels were logical, as the groups with the highest BMP-2 concentrations had the highest 
amount of anti-noggin antibody binding. If nothing else, this confirms that the growth factor 
has biological activity, as the suggested model of noggin expression is a negative feedback 
loop: the more BMP-2 is present, the more noggin is excreted to counter act it (Chen, et al. 
2012).  The idea of using noggin inhibitors for boosting the activity of bone morphogenetic 
proteins has been studied and patented (Wan DC, et al. 2007; Chen, et al. 2012), so it would be 
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interesting to see if their use would make the effects of BMP-2 statistically significant. Fan and 
coworkers combined BMP-2 agonists and noggin antagonists with genetic modification and 
BMP-2 in a recent study and gained great results in differentiating hASCs into osteoblasts(Fan, 
et al. 2016). Such a set up with could potentially lessen the variation between cells from 
different donors and thus be more generalizable. 
When all the data is analyzed, the results indicate that the CTRL scaffolds are more osteogenic 
than plain wells and that the BMP-2 scaffolds are more adipogenic than the CTRL ones. 
Whether this is due to the weakening of the scaffolds mechanical properties due to drug loading, 
possible adipogenicity of low BMP-2 concentrations, or both is hard to discern at this time. 
Addition of BMP-2 to the medium increases osteogenic differentiation more on CTRL scaffolds 
than on plain wells. In conclusion it seems that CTRL scaffolds combined with BMP-2 in 
culturing medium, especially in OM is suitable for osteogenic differentiation of hASCs. 
6.2 Evaluation of used methods 
All the techniques used in this study have been used excessively in the field. Due to this, using 
these methods makes it possible to compare the results to literature.   
6.2.1 Cell proliferation and viability 
CyQuant is based on total ribonucleic acid (both DNA and RNA) amount and not absolute cell 
count such as staining of the nuclei. Due to this it has its inaccuracies, but steps were taken to 
minimize them. These steps included washing the biomaterials with PBS prior to lysing the 
cells as well as doing the sample collecting from the scaffolds systematically the same way with 
all the samples. This should be sufficient to get rid of the influence of dead cells.  
While Cyquant proliferation assay is a good method to measure the relative amount of cells in 
a sample, it would have been informative to utilize a method to assess the viability of the cells. 
Cyquant cannot be used to distinguish between live and dead cells, so it is possible that some 
residual from dead cells remained in the samples after removing the medium and the PBS 
washes. qALP and Alizarin red -staining are related to cell numbers so the interpretation of 
those analysis results are also affected. Light microscopy could not be used to follow the cells 
during the majority of the tests, due to the material not being translucent. A live dead assay 
utilizing fluorescence could have been useful for checking the viability of the cells for more 
accurate results. Another option would have been to use FACS to count the live and dead cells 
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from a cell suspension, but detaching the cells from the material in a consistent way would have 
required additional testing beforehand. While such analysis would have been possible, it is 
worth noting that as the number of scaffolds was limited adding more analysis would have been 
impossible without omitting something else. Furthermore some of the cells were firmly 
embedded in the material, so there was no good way to detach them for FACS.   
6.2.2 Cell-material interactions and morphology 
Oil Red O stains not only the intracellular fat vacuoles but also to the material. This is useful 
for imaging and studying the scaffold-cell interaction with fluorescence microscopy. While the 
binding to fat vacuoles is not specific per ce, but rather due to hydrophobicity, there are virtually 
no other structures inside the cell that the stain can bind to. 
It would have been more informative to obtain confocal microscopy images of the cells on the 
material to see how deep into the material the cells could invade. From the 2D images it can 
only be seen, that some appendages of the cells grow under the threads of the material.  
Scanning electron micrographs of the materials with and without the cells would also have been 
informative. It would have been more accurate to measure the thread and bead diameters with 
micrographs than from fluorescence microscopy images, as the resolutions are quite different. 
Actin labeling is good for studying cell shapes, but in hindsight it might have been more 
interesting to focus on other aspects such mechanobiology, which could be better explored, if 
immunofluorescent labeling was used on talins, vinculins or other components of focal 
adhesion complexes. This would make it possible to compare their numbers and give qualitative 
information about the mechanically activated cell signaling pathways, such as the non-
canonical wnt-pathways that have been shown to be important for osteogenic differentiation. 
This kind of analysis would however be more easy and accurate to conduct with the help of 
confocal microscopy. Due to the limited number of filters in the fluorescent microscope and 
the scarcity of the scaffolds, this could not have been done simultaneously with morphological 
studies that required phalloidin.  
Actin labeling is extremely useful for studying cell shapes. Similarly ORO staining is a simple 
method to see the intracellular fat and the material at the same time, however, this simplicity 
comes at the cost of not always being able distinguish between intracellular fat and the 
biomaterial: the vacuoles were distinguishable from the material only by their shape, which is 
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qualitative. ORO staining just as Alizarin red staining can be quantized and has been used to 
study adipogenesis. However ORO quantitation could not be carried out in this study, as the 
stain binds to the scaffold material. The products of the biomaterial hydrolysis are likewise 
stained with the stain: their size can be in the same order of magnitude as the fat vacuoles, 
causing further confusion. Nevertheless the many washes during sample preparation and the 
shape of the vacuoles, made it possible to identify intracellular fat most of the time without 
problems. To obtain better images it could have been a good idea not to use a mounting agent 
with DAPI and just stain the nuclei separately. DAPI has the tendency to overstain, creating 
shadows on the images. Applying the same amount of staining agent on all the preparations is 
not easy, due to the low viscosity of the reagent and the scaffolds not being flat. As a result 
DAPI overstaining occurred in several samples. However while this made obtaining quality 
images harder, it did not affect the results of the study. 
6.2.3 Early differentiation and mineralization 
The differentiation towards osteogenic lineage was assessed using qALP- assay and Alizarin 
red staining, as previously discussed. The final quantification from the samples was done by 
using colorimetric methods with a plate reader. As such the limitations of colorimetry apply to 
the reliability of the results. Plate readers have upper and lower limits of detection for different 
wavelengths. Below the lower detection limit nothing can be measured. Similarly above the 
upper limit, the samples cannot be quantified. These limits greatly dependent on the plate 
reader. 
Alizarin red staining, while the most used method for studying mineralization, can be biased, 
as it does not differentiate between calcium from the ECM and calcium released from dead 
cells. Therefore it is important to relate the results to cell numbers. Optimally the cell count 
should be taken from the same wells, as the samples for Alizarin Red, but as the conditions are 
the same, the error is not great even in this study. Furthermore steps were taken to minimize 
influence from the dead cells in the sample preparation protocol, as there were several washes 
before and after fixation. The upper detection limit was reached several times in the last time 
point measurements in this study, which might downplay the accuracy of the normalized results 
and explain the discrepancy seen in OM BMP-2 scaffold group at 21, where the results indicate 
opposite things.  
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ALP activity is important for mineralization as it provides the ECM with phosphate ions. It has 
been used to detect early differentiation and is a standard in the field. It is important to 
remember that enzyme activity can fall with multiple freeze thaw cycles, so in order to avoid 
differences between the samples due to ALP deactivation, the number of freeze thaw cycles 
was always the same. Other things to keep in mind are the detection limits of this method. In 
the assay, the enzyme incubation time has to be kept constant between samples, however it is 
possible that some samples have such high enzyme activity that the detection limits are 
exceeded. In this study the detection limit was not reached with ALP samples. 
6.2.4 Serum starvation conditions 
Serum starvation is used most often for cells intended for WB samples, when studying 
phosphorylation in response to stimulus. The condition is stressful for the cells and culturing in 
these conditions is not normally used for more than 7 days. In this study the effects of BMP-2 
on SMAD phosphorylation are highlighted when the cells are deprived from other signal 
molecules they would normally receive from serum in the culturing media. Starvation also 
synchronizes cell cycles. The differences in protein and gene expression become clearer, but at 
the same time one might question if the results are relevant as the conditions differ greatly from 
normal ones. Furthermore, results vary from cell line to cell line, as for example some cancer 
cells thrive in the absence of serum, whereas detrimental effects can be seen in the survival of 
normal cells. Considering this study, one might argue that as adipose cells act as energy 
reservoirs of the body and adipose differentiation occurs in vivo when the body is in a state of 
anabolism, that in starvation, the cells are unlikely to differentiate into adipocytes. The qPCR 
results are interesting in this sense, as they nonetheless hint at higher adipogenesis than 
osteogenesis under these conditions. 
The amount of cells seeded might be one factor that affects the outcome of this study. Regularly 
MSCs are seeded onto scaffolds in higher concentrations than on plain wells, as many of the 
cells do not properly attach to the scaffold at first. The seeding concentrations in previous 
studies performed in our group have ranged from 5000 to 10000 cells/1,9cm2, while 
considerably lower seeding concentrations have been used for plain wells. One reason why 
more cells were seeded in condition II was because the lower serum concentration is harmful 
for cell survival. However, as higher cell concentration is considered beneficial to adipogenic 
differentiation, the conditions the results are not readily comparable to those received from 
condition I. While the effects of BMP- are somewhat clear from the qPCR results, due to the 
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difference in cell numbers between two experimental setups should be taken into account when 
considering the adipogenic properties of the material alone. However as MSCs proliferate better 
on plain plastic than on the scaffold material, this is a necessary compromise. 
Moreover, looking at Figure 17, which summarizes the results of qPCR results, it becomes 
obvious why serum starvation is not usually carried out for longer periods of time. The 
measurements at 14d should not be considered too rigorously, but it is interesting to note that 
at 14d osteogenic markers are down regulated, whereas the adipogenic ones up-regulated. This 
makes sense, when considering the metabolic activities of osteoblasts and adipocytes: 
Osteoblasts need to produce considerable amounts of collagen and other extracellular proteins, 
whereas adipocytes specialize in energy preservation. 
6.2.5 Western Blotting 
The biomaterial used seemed to hinder WB analysis. Previously used PLA-scaffolds gave no 
background on the films with the same SOP, whereas the scaffolds used in this study made the 
films difficult to read. It is a possibility that partly degraded negatively charged polymer 
particles in the samples loaded to the gel also travel to the membrane as the proteins are 
transferred. However, a more likely scenario is that the background was caused by a poor choice 
of blocking medium: Phospho-sensitive antibodies often bind to casein in the milk, resulting in 
nonspecific binding (www.abcam.com/technical(12.12.2015)). However, in earlier studies 
conducted in the Adult stem cell group, contrary to literature, milk blocking has yielded better 
results. 
Another thing to consider with WB is the use of nitrocellulose membrane instead of PVDF 
membranes. While PVDF membranes bind more proteins than nitrocellulose this can cause a 
lot of noise in the signal. The protocol for transfer was however optimized for PVDF 
membranes, but had worked well before so there was no reason to try to change it for these 
particular samples. Especially as the PSMAD levels has proven to be hard to detect: The volume 
of sample loaded for PSMAD detection was as high as possible for the used gels –and six times 
higher than for β-actin detection. This justifies the use of the higher binding PVDF membranes 
over the more accurate nitrocellulose ones. 
It might have however been more informative to use enzyme linked immunosorbent assay 
(ELISA) detection instead of, or in parallel with WB. While WB confirms the masses and 
identities of the proteins, ELISA is a more quantitative and a more sensitive method. The 
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protein and DNA-level results could have been related even better if the methods were both 
quantitative. One way to make WB more quantitative is to use software to compare the levels 
of luminescence instead of using x-ray films and old-fashioned developing machines. This 
semi-quantification can be done afterwards, as was done in the current study. The background 
was high in the blots, so semi-quantification might not be very accurate.  It is however good to 
keep in mind that WB even at its best is only semi-quantitative. Noggin WB results could not 
be scanned as discussed earlier, but they were in agreement with the qPCR results, showing 
higher expression with higher BMP-2 concentrations. 
6.2.6 qPCR 
While looking at qPCR results, it is important to realize that mRNA-levels do not always 
correlate with protein expression levels. They do however indicate the activation of signaling 
routes as mRNA is not transcribed without the action of transcript factors that themselves need 
activation through signaling. As such the results are a good indication of differentiation, if the 
genes under surveillance are well chosen. In this study DLX5 and OSX were chosen as markers 
for osteogenesis where as HAP2 and PPARg were chosen for adipogenesis. These same markers 
have been used in earlier studies (Tirkkonen L, et al. 2011; Tirkkonen, et al. 2013a).  
The timing of each genes’ activation in the process of differentiation have been extensively 
studied. OSX is expressed prior to DLX5 and is typically not expressed after the first week, due 
to methylation(Hagh, et al. 2015).  Likewise, PPARg is expressed prior to AP2.  
The use of SYBR green is not the most accurate method in qPCR. SYBR green binds to double 
stranded DNA and this binding can be detected in the form of fluorescence. As the amount of 
DNA increases, so does the fluorescence. SYBR green does not differentiate between primer 
dimers and double stranded DNA. In this kind of study, where the absolute DNA concentrations 
are not as important as their relative amounts between groups, it is however sufficiently accurate 
method. 
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7. CONCLUSIONS 
Electrospun PLGA-PCL scaffolds with loaded BMP-2 do not give enough mechanical support 
to induce osteogenic differentiation of hASCs. Instead the material seems to support adipogenic 
differentiation. The same material without drug loading however seems like a good material 
for osteogenic differentiation, especially with BMP-2 added in the culture medium. This result 
supports the claim that the mechanical properties of the cell substrate are a very important factor 
in deciding the cell type hASCs differentiate into. The experiment also shows that BMP-2 has 
less effect on osteogenic differentiation than osteogenic medium, which contains a number of 
other soluble factors that are associated with osteogenesis. The combination of BMP-2 with 
OM however seems beneficial for osteogenesis. While no statistical significance was found in 
this study between the different conditions, assumably due to great variation caused by 
differences in cells derived from different patients, the overall trends were clear. However, for 
future studies a more hydrophilic and stiff material should be used for scaffolds and noggin 
antagonists and BMP-2 agonists could further help the osteogenic differentiation. Alternatively 
another growth factor, one that inhibits adipogenesis rather than promotes osteogenesis, could 
be tried in combination with the material. 
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